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 In the last two decades nanotechnology market has undergone remarkable growth. 
Breakthroughs in nanomaterial synthesis increased diverse nanomaterials production and 
subsequently their application. Owing to its large surface to volume ratio and remarkable 
physical properties not seen in the bulk materials, nanoparticles are finding emerging use 
in industry and medicine. Hence, it is expectable that at some point these nanomaterials 
will end up released into the environment and interact with bio systems. The purpose of 
this dissertation is to elicit implications of nanomaterial transformation once it gets inside 
biological milieu. 
 After literature review and introduction given in Chapter 1, Chapter 2 will discuss 
toxic effect of single and multi-walled carbon nanotubes (SWCNT, MWCNT) onto cells, 
once these nanoparticles’ surface gets covered by blood plasma protein - fibrinogen, 
forming so called protein corona. Although, experimental technics enable protein corona 
characterization trough measuring binding affinities, protein residence time and detection 
of protein conformational changes, my curiosity to understand this phenomenon on 
molecular level, led me to use of computational approaches like molecular dynamics. 
 In Chapter 3 we will explore formation of nanoparticle-protein corona, using 
molecular dynamics methods and try to understand at molecular level, genesis of this 
entity. Our model system will consist of silver nanoparticle covered in citrate and 
ubiquitous protein found in every eukaryotic cell-ubiquitin.  
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 Chapter 4 will deal with protein corona evolution on graphene and graphene oxide 
surface, where we will see how binding affinity and concentration of different natural 
amphiphiles determines corona composition over time. 
  Chapter 5 will explore how the surface chemistry of fullerenes affects protein 
stability.  Fullerene surface is randomly covered with different number of hydroxyl 
groups, controlling its degree of hydrophobicity.  
 Finally, Chapter 6 will examine impact of nanomaterials on protein aggregation 
propensities. A lot of experimental studies found out that some nanoparticles promote 
while other hinder protein aggregation. We will try to delineate how interaction strength 
between nanoparticle surface and protein residues, relative concentration and protein 
stability influence aggregation tendency.  In Chapter 7 will be given brief conclusion and 
future course in the field. 
 The aim of this study is to investigate at molecular level influence of 
nanoparticle-protein interaction on protein structural changes, binding affinities and 
aggregation which eventually can have beneficial or adverse effects onto biological 
system. Studying these interactions will give us better understanding of the fate of 
nanomaterials in biological milieu and help set future directions of their safe application 
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1. Introduction: Nanotechnology Market Growth 
Two decades ago, an IBM scientist named Don Eigler constructed his employer 
company logo in letters by manipulating individual atoms. This endeavor was visual 
embodiment of scientific advancement that indicated power of nanotechnology to rebuild 
matter by manipulating atoms and molecules to obtain desired properties. The National 
Scientific Foundation (NSF) established its first program dedicated to research in 
nanotechnology in 1991, but only in the beginning of 21st century disintegrated fields of 
nanoscience and engineering were brought together under the same ten years vision 
outlined in Nanotechnology Research Directions1. This proposal was adopted in 2000 as 
official document of National Science and Technology Council (NSTC) and pawed the 
road for rapid emergence of nanotechnology in the beginning of 21st century. 
NSF and NNCO-funded independent study spotted more than 1 trillion in global 
revenue form nano-enabled products just in 2013 (see 
http://www.nsf.gov/news/news_summ.jsp?cntn_id=130586&org=NSF&from=news). 
Also, Innovative Research and Products analysts identified rapid growth in approved 
patents related to nanotechnology2 (Figure 1.1). For example, just in 2008 there were 
around 10,067 patent applications filed per year2. Whether it is development of 
nanotechnology based solar panels, novel cancer treatment or bio imaging, predicted 
growth of this emerging market for 2014-2020 period is 16.5 % as drawn in 
Nanotechnology Market Outlook 2020 by RNCOS’ analysts3. 
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Recognizing the advantage of targeted drug treatment and promising use of 
nanomaterials as drug delivery vehicles, healthcare industry is poised to be among the 
first ones to see benefits of nanotechnology. Cientifica’s report, Nanotechnology for 
Drug Delivery 2012, gives analysis and geographical breakdown of nanotechnology drug 
delivery market4. The market growth for 2000-2010 shows it reached 1,030 million USD.                           
 
 
Figure 1.1. Growth in reported nanotechnology based application over time2. Springer and 
Journal of Nanoparticle Research, Vol. 12, 2010, pp 687-706, Trends in worldwide 
nanotechnology patent applications; 1991 to 2008, Dang ,Y., Zhang, Y., Fan, L., Chen, H. & 
Roco, M. C., Fig. 1 Copyright © Springer Science+Business Media B.V. 2009is given to the 
publication in which the material was originally published, by adding; with kind permission from 





2. Nanomaterials: Properties and Applications 
Particles with at least one of three spatial dimensions less than 100 nm are termed 
as nanoparticles. They generally come in different shapes, sizes and chemical structure. 
Ranging from metallic (Au, Ag, Cu, Fe), semiconducting (quantum dots), carbon based 
(nanotubes, fullerenes, graphene, nano-diamonds) to polymer and co-polymer based 
nanoparticles; these materials are finding colossal potential use in industry, biomedicine 
or pharmacology5–9. 
 
Metallic nanoparticle. Metallic nanoparticles are ideal candidates for use in bio-imaging 
due to unique physicochemical properties that enable these nanomaterials to act as 
contrasting agents10. Gold nanoparticles, also called colloidal gold, is suspension of nano-
sized particles of gold. Depending on its diameter, the color of this suspension can be red 
for nanoparticles less than 100 nm to yellow for larger nanoparticles11,12 (Figure 1.2). 
Also, depending on the shape of gold nanoparticles their color can be changed and this is 
seen especially in the case of gold nano-rods. These interesting optical properties of gold 
nanoparticles are due to their specific interaction with light13. Once electromagnetic wave 
(EM) reaches the surface of gold nanoparticle it interacts with free electrons near the 
metal surface, forcing them to oscillate14. This process termed as localized surface 
plasmon resonance (LSPR) has characteristic resonant frequency, at which is seen EM 
absorption peak. Once EM wave is absorbed, excited plasmons dissipate energy through 
the light scattering or heat. 
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Owing to its optical properties gold nanoparticles are finding use in targeted bio imaging. 
Antibody-conjugated gold nanoparticles allow real time detection of penetration of gold 
particles into living cell at single molecule level by utilizing confocal microscopy 
method15. The basic concept of this technique is that object luminescence is excited by 
absorption of one or two photons with lower energy compared to the one needed for 
fluorescence. The advantage of this method is in reduction in noise to signal ratio and 
increase in contrast. Utilizing this benefit of gold nanoparticles, they are being used as 
tumor markers on the surface or inside the cell16. Also, dark field microscopy based on 
the light scattering from the objects, including the objects with size lower than the 
resolution of the microscope is one of the most popular techniques using gold 
nanoparticles in imaging17. As the scattering cross section of particle is 3-5 orders of 
magnitude than of fluorescence labels15, gold nanoparticles are exploited to enhance 
visualization against the dark background. Once functionalized with proper antigens, 
these nanoparticles can preferentially bind or penetrate into tumor cells and in that way 








Silver nanoparticles (AgNP) are nanoparticles of silver ranging in size18 from 1 to 
100 nm. Their antimicrobial properties are the most explored ones19–21. The advantage of 
using nanoparticles compared to other chemical antimicrobial instruments is that 
microorganisms will be harder to become resistant to nanoparticles’ antimicrobial effect.  
The exact mechanism of AgNP antimicrobial action isn’t fully understood, but some 
studies suggest that silver ions play the major role22 through electrostatic interaction 
between positively charged Ag ions and negatively charged microorganism membrane. 
On contrary, other study reported that destructive effect of AgNP on gram-negative 
bacteria was dependent on nanoparticle concentration and associated with formation of 
“pits” in the cell wall of bacteria23,24.  Using electron spin resonance spectroscopy, 
studies found that when in contact with cell membrane, AgNP promote release of free 
radicals that subsequently damage cell membrane19,25. Putting aside detailed mechanism 
of silver nanoparticles microbial inhibitory effect, these studies suggest that AgNPs can 
be used as effective growth suppressant in different microorganisms, setting them as ideal 
candidates for medical devices.  
 
Quantum Dots. Similarly to metallic nanoparticles, quantum dots’ (QDs) optical 
properties are size and shape tunable26,27. As the size of QD decreases the band gap 
increases (Figure 1.4.).  For example, highly luminescent CdSe QDs are potential 
materials for use as optoelectronic devices, and in vitro and in vivo imagining and 
analyses. Due to exceptional photostability and bright emission, broad absorption and 
narrow emission bands and large two-photon absorption cross-section29, QDs are seen as 
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ideal substitution to organic fluorophores. Functionalized with specific ligands, these 
bioconjugated QDs effectively bound to targeted cell membranes30 pawing the road to 
use of quantum dots as excellent probes for detection and imaging of cells. The 
endocytosis31 of QDs was reviewed by Parak et al. Hydrophilic QDs entered cell via 
endocytosis and aggregated inside the cytoplasm32. Conjugated Tat peptides with QDs 
were delivered inside human fibroblast cells and the nucleus of COS 1 cells33. These 
studies point into promising application of QDs as targeted drug delivery vehicles.  
 
Figure 1.4. QD spectra. Absorption (full line) and emission spectra (dashed line) of different 
size QDs in range of 20-55 Å 26. From Alivisatos, A. P. Semiconductor Clusters, Nanocrystals, 
and Quantum Dots. Science 271, 933–937 (1996). Reprinted with permission from AAAS. 
 
Carbon-based Nanoparticles. Owing to their unique physical and chemical properties 
like mechanical strength, thermal and electrical conductivity and optical properties, 
carbon based nanomaterials are finding increasing application in electronics and novel 
high-strength materials34,35. Carbon nanomaterials can be chemically functionalized 
which increases their solubility and makes them suitable for biomedical use. The most 
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common carbon nanomaterials are graphene, carbon nanotubes and fullerenes (Figure 
1.5.). 
 
 Figure 1.5. Graphene, carbon nanotube and fullerene36. Reprinted figure with permission 
from Castro Neto, A. H., Guinea, F., Peres, N. M. R., Novoselov, K. S. & Geim, A. K. The 
electronic properties of graphene. Rev. Mod. Phys. 81, 109–162. Copyright 2009 by the American 
Physical Society. 
 
Graphene is 2D allotrope37 of carbon and first was isolated by Novoselov in 2004. 
Even though it is produced every time someone writes with pencil, no one expected 
graphene to exist in the free state and also, no tools existed to insulate one-atom thick 
layers among pencil debris38. Basically, graphene is made of carbon atoms arranged in 
honeycomb structure made out of hexagons (Figure 1.5.). Carbon atoms form σ and π 
bonds through sp2 hybridization. The length of σ bond between two carbon atoms is about 
1.42 Å and is responsible for robustness of the structure in all allotropes, while π orbitals 
due to strong tight-binding are contributing to strong collective effects, magnetism, and 
insulating behavior39,40. In biomedical applications, functionalized form of graphene, 
called graphene oxide (GO) is more used due to better suspension41,42. The intrinsic 
photoluminescence of GO is exploited for live cell imaging in the visible and near 
infrared43. Also, it was shown that doxorubicin, a widely used cancer drug, can be loaded 
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to graphene oxide and delivered to tumor cells44 (Figure 1.6.).  GO displays advantageous 
characteristics to be used as biosensing platform due to easy functionalization with 
biomolecules and tunable electronic properties that can make this functionalized GO to 
be insulator, semiconductor or semi-metal45. The hexagonal lattice of GO interacts 
strongly with aromatic structures in nucleotides through π-π stacking46,47, also studies 
reported absorption of peptide onto GO surface48–50. As the oxidation process causes 
defects in planar structure of GO, leading to disruption of sp2-bonded carbon atoms in 2D 
lattice, GO possesses a recombination electron-hole pairs localized in sp2 region of a sp3 
matrix, displaying photoluminescence characteristic51. 
 
Figure 1.6.  A scheme showing loading of doxorubicin (red) onto graphene-oxide-PEG-
Rituxan44 
 
Depending on the reduction processes, fluorescence emission spectra can be 
changed, opening opportunities for tailored optoelectronic properties45.  Having in mind 
these GO characteristics, graphene oxide is finding use as a FRET donor, and owing to its 
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semi-metallic properties it can be used as FRET acceptor as well and being applied as 
biosensing platform in biomedicine45. 
Carbon nanotubes are tubular structures with sp2 hybridized carbon atoms. The 
carbon nanotubes (CNT) can consist of one (single walled CNT) up to hundreds 
(multiwalled CNT) concentric carbon shells52 adjacently separated by 0.34 nm. The 
quasy-one dimensional structure is responsible for high Young’s module and tensile 
strength, so these materials are used in novel composite materials53,54. Also, depending on 
their structural parameters, CNT can be metallic or semiconducting, making them ideal 
candidates for novel electronic devices, including field-effect transistors (FETs), single 
electron transistors and rectifying diodes55. Recently they are investigated as possible 
hydrogen energy storage units56. Application of CNT in biomedical field is recently 
emerging57, ranging from use of CNTs as DNA and protein biosensors, ion channel 
blockers, biocatalysts and in tissue engineering58–62. They are being used to specifically 
detect antibodies63 and similarly DNA58 when appropriately functionalized. Due to their 
large surface area, CNT can be loaded with different drugs and specifically delivered to 
targeted cell, which is necessary for efficient tumor treatment64–66. A study showed that 
application of drug loaded CNTs onto specific cells was more efficient compared when 
just free drug was used67. All these examples corroborate promising application of CNTs 
in biomedical and pharmaceutical industry. 
 Kroto et al. discovered fullerenes in 1985 and in 1996 this discovery led to Nobel 
Prize to Kroto, Curley and Smalley. Fullerene family is composed of carbon atoms 
forming ellipsoid, tube or spheres. The spherical fullerenes are also called buckyballs. 
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The C60 molecules possess high symmetry and are one of the most symmetric molecules 
known68.  They are made of 20 hexagons and 12 pentagons and all double bonds are 
conjugated. Despite aromatic character of the bonds, C60 behaves more like electron-
deficient alkanes69.  These molecules are highly hydrophobic and tend to aggregate in 
solution70, thereby non-conjugated fullerenes are of limited use in biological systems. 
Luckily, there are several developed techniques to increase fullerene solubility like 
encapsulations in special carriers-micelles and liposomes, calixarens , cyclodextrins or 
polyvinylpyrrolidon , then suspensions with the help of co-solvents and finally chemical 
functionalization to decrease hydrophobicity with addition of poly-hydroxyls, amino and 
carboxyl acids or amphiphilic polymers71–77.  It has been shown by Friedman et al. and 
others that fullerene derivatives can inhibit HIV-1 replication by fitting into cavity of 
HIV-1 protease78–80. Further, Shoji et al. showed that fullerene derivatives have inhibitory 
effects on influenza A virus by interacting with PA subunit of H1N1 and H5N1 
protease81.  Fullerenes were recognized as excellent sensitizers for production of singlet 
oxygen82. This property of fullerenes was exploited to cleave DNA by photo activation83.  
Due to its lowest unoccupied molecular orbital and conjugated double bonds, fullerene 
are ideal electron acceptors, making an attack on free radicals very likely. This feature 
makes fullerenes radical scavengers84 and when localized inside the cell mitochondrion, 
where in the case of diseases free radical species are produced, fullerene can act as 
radical sponge and have protective properties for the cell85. By attaching hydrophilic 
groups to the fullerene surface and making them water soluble, these carbon 
nanostructures become capable of drug or gene delivery to the cells. Fullerene size is 
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about 1nm, and studies by Isobe et al. and Nakamura et.al showed that fullerene can enter 
COS-1 cells with comparable or better efficiency compared to common used lipid 
vectors86. Foley et al. demonstrated crossing of fullerenes though cell membrane and 
binding to mitochondria87.  Prospective use of fullerene is seen in cosmetic industry, 
owing to binding of fullerene to collagen and making collagen fibers stiffer88, opening the 
doors to slowing down aging of the skin. An example of high definition TEM image of 
functionalized fullerene is shown in Figure 1.7.  
 
Figure 1.7. HRTEM images of functionalized fullerenes (different rotation angle view a-c)  d-f 
simulated TEM images and g-i schematic image89. Reprinted with permission from Liu, Z., 
Suenaga, K. & Iijima, S. Imaging the Structure of an Individual C60 Fullerene Molecule and its 
Deformation Process Using HRTEM with Atomic Sensitivity. J. Am. Chem. Soc. 129, 6666–
6667. Copyright 2007 American Chemical Society. 
 
3. Nanomaterials in biological milieu: Transformation and Toxic Effects 
Enormous growth in production and application of nanomaterials raised concerns about 
possible toxic effect of these materials onto the environment and the biological system. 
13 
 
The use of nanomaterials in cosmetics, food production, nanomedicine, detergents raises 
concern that eventually they can end up released into the freshwater or marine 
ecosystems through sewage systems, and latter through food chain or inhalation end up in 
the biosystem90–92 as illustrated in Figure 1.8.   
  
Figure 1.8.  Illustration of food chain routes that could lead to human exposure to 
nanoparticles. Adapted with permission93 of the Royal Society of Chemistry. 
Once nanoparticles get into the biological environment their surface gets coated 
with various biomolecules, forming so called protein corona94 (Figure 1.9.). It’s rather 
protein corona than the pristine nanoparticles that determines the fate of nanoparticle in 
biosystem 94.  Thus it is very important to characterize affinities, rates and stoichiometry 
of protein binding to the NPs surface in order to understand nanomaterials interaction 
with cells and its machinery.  The rates at which proteins bind to nanoparticle surface can 
define its interaction with cell receptors. Tightly bound proteins with slow exchange rates 
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(hard corona) might follow the nanoparticle as it undergoes endocytosis, while loosely 
attached proteins could be replaced during this process with proteins found in cytoplasm 
determining the interaction between NPs and the cell environment. The lifetime of 
protein-nanoparticle complexes depends on the specific protein and nanoparticle type, but 
typically ranges from 100 s to many hours95–99. Cedervall et al. in study of protein corona 
formation between human serum albumin (HSA) and copolymer N-isopropylacrlamide 
(NIPAM): N-tert-butylacrylamide (BAM) nanoparticles, revealed stoichiometry 
dependence on hydrophobicity and size94.  Copolymer particles with higher BAM content 
are more hydrophobic. In this study 85:15, 65:35 and 50:50 NIPAM:BAM NPs are used. 
Utilizing isothermal titration calorimetry (ITC) they showed that the number of proteins 
bound to more hydrophilic NPs (85:15) was about 60 while for hydrophobic one was 
about 350 (50:50), suggesting higher stoichiometric ratio for more hydrophobic particles. 
Also, as they increased the size of BPs from 70nm to 200nm they observed increase in 
bound protein to 980 and 5400 for 85:15 and 50:50 NIPAM:BAM NPs, respectively. 





Figure 1.9. Nanoparticle-corona complex a) and relevant processes b) for NP interacting with 
receptor. Reprinted by permission from Macmillan Publishers Ltd: Nature Nanotechnology100, 
copyright (2012) 
nance (SPR Figure 1.10.) and size exclusion chromatography revealed that protein 
exchange rates depend om hydrophobicity.  
 
Figure 1.10. SPR A) Cartoon of a gold surface and associated protein over buffer is flown.  B) 
and C) SPR data of plasma proteins injected overn70 nm 85:15 (blue) and 50:50 (red) 
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NIPAM:BAM NPs for 30 min B) and 24h C) 94.  Copyright © by the National Academy of 
Sciences HSA residence time on more hydrophilic particles is longer, compared to the 
hydrophobic ones. Further, they repeated experiment with fibrinogen, other blood plasma 
protein, and results showed that fibrinogen residence time on NPs is longer.  
 Additional experiments with blood plasma that consists of more than 3700 
different proteins and NIPAM:BAM nanoparticles were conducted. It was found that 
several plasma proteins preferentially bound to the surface of copolymer nanoparticles 
and that at least six of them elute faster than HSA, implying slower exchange with the 
NPs surface. After, three cycle centrifugation of 20 min, albumin and fibrinogen 
SDS/PAGE signatures weren’t observed, while some other plasma proteins (175, 75, 50, 
35 and 28 kDa) were identified to bind the surface. Depending on the protein, binding 
amount was or wasn’t dependent on nanoparticle’s hydrophobicity. This study uncovered 
complex mechanism of nanoparticle-protein interaction, which depends on the protein 
type, nanoparticle surface properties and that some proteins form transient complexes 
with nanoparticles and the final corona composition is determined by competitive 
binding. Centrifugation experiments in above mentioned study, suggested two types of 
protein corona: soft corona, in which protein dissociates from nanoparticle surface and is 
in equilibrium with free protein in solution and hard corona, tightly bound protein with 
very slow dissociation rates. Milani et al. studied formation of transferrin protein corona 
using fluorescence correlation spectroscopy (FCS) methods101. They observed genesis of 
monolayer protein corona, up to nanoparticle surface saturation, followed by formation of 
the second protein layer. Protein that formed first monolayer is found to be tightly 
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absorbed to nanoparticle surface and formed hard corona, while weakly bound second 
monolayer formed soft corona. Further, this study noted two different adsorption 
processes, one describing protein adsorption to surface through protein-surface 
interaction and the second process involved in formation of the second layer through 
protein-protein interactions. When other plasma proteins were introduced together with 
already formed transferrin-nanoparticle corona, transferrin from the second layer, labeled 
as soft corona was replaced by plasma (Figure 1.11.). 
 
Figure 1.11. Competitive unbinding: Hard corona (HC) (black circle 5% and black squares 10 
% added plasma); red, blue circles (5% added  plasma on two different types of NPs) and red 
squares (10 % added   plasma) representing soft corona (SC)101. Reprinted with permission from 
Milani, S. et al. “Reversible versus Irreversible Binding of Transferrin to Polystyrene   
Nanoparticles: Soft and Hard Corona”.  Copyright 2012 American Chemical Society.             
 
 Transportation of nanoparticles through food chain and impact of polystyrene 
nanoparticles onto fish behavior and fat metabolism90 was investigated by Cedervall et al. 
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Polystyrene nanoparticles of 24 nm size were fed to an algal culture, which then was 
filtered and fed to herbivorous zooplankton (Daphnia). After 24 h the zooplankton was 
washed, so residual surface bound nanoparticles were removed and then the zooplankton 
was given to top consumer, fish (Figure 1.12.). The control food chain was operated in 
the same way, except that no nanoparticles were given. It was noticed that nanoparticle 
fed test fish let Daphnia swim out their mouth and in general exhibited lethargic 
behavior. Polystyrene nanoparticles bind several apolipoproteins form human plasma102 
and one of them is apoA-I. ApoA-I and HDL proteins are essential for fat metabolism. It 
is likely that polystyrene nanoparticles travelled through intestine wall and entered blood 
stream, binding apoA-I and HDL proteins and influencing fat metabolism.  After 
comparing triglycerides: cholesterol ratios  of test and control fish, it was observed that 
after 14 days this ratio remain the same, but after 22 days drop was seen in the control, 
while minor changes in the test. Also, after 22 days increased concentration of cholesterol 
in liver was observed. Fish was fed with limited amount of zooplankton, so the drop in 
weight was expected. A significant weight loss was seen in control fish, while in the test 
fish weight remained the same, implying that nanoparticles interfered with metabolic 
process and blocked utilization of energy reserves. This   study   showed     that protein 
corona formation can have devastating effect on metabolism of the top consumer and as 






Figure 1.12. Food Chain. Scheme depicting process of feeding zooplankton with 24nm 
polystyrene NPS, and then after zooplankton was washed, it was given to top consumer-fish90 
 
 Lin et al. showed that C70 and multiwalled carbon nanotubes (MWCNT) can be 
taken and transferred to next generation in rice plants91. They saw that nanoparticles were 
found in roots, stems and leaves of the two weeks old first generation rice plants and later 
in seeds. The appearance of nanoparticles in the zones of plant vascular system suggests 
that uptake of NPs happened simultaneously with the uptake of water and nutrients in the 
xylem. Furthermore, no nanoparticles were detected on roots of mature plants suggesting 
powerful transport of nanomaterials from the roots to the leaves. Also in the leaves of the 
second generation plants C70 nanoparticles were observed, indicating transmission of 
nanoparticles from seeds of the first generation to the next one. Contrary to C70 uptake of 
MWCNT was insignificant at concentrations of 20 to 800 mg L-1 with some observed 
aggregates near the vascular system. At concentrations of 400 mg L-1 of C70 flowering of 
the plant was delayed by 1 month and seed setting rate reduced by 4.6%. At high 
concentration of C70 and therefore its aggregation in the vascular system of the plant, it is 
expected that these NPS would interfere with normal uptake of water and nutrients 
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necessary for the plant growth and in that way hinder its development. Similarly, with 
high concentration of MWCNT (400 mg L-1) due to NPs induced blockage of the roots 
leading to the hindered uptake of water or nutrients, flowering of the plant was delayed 
for 1 month and the seed setting rate reduced for 10.5%. These two studies, one dealing 
with impact of nanoparticles on fauna and the other on flora uncover hazardous potential 
of nanoparticles onto the ecosystem and their propagation through the food chain, finally 
reaching human biosystem.  
 
 Nanotoxicty. In the next couple of paragraphs, I will briefly describe toxic effects 
of different nanoparticles in different cell structures and mammals. Protein adsorption to 
nanoparticle surface can mediate the uptake of nanoparticles through receptor mediated 
endocytosis103 (RME). Influence of nanoparticle surface charge, functional groups, 
protein corona, size and intrinsic physico-chemical properties would be assessed in 
connection to potential toxic effects onto cell cultures.  
 Review by Alkilany et al. summarized the state of the toxic studies on gold 
nanoparticles done done by 2010104.  In studies carried out, gold nanoparticles of sizes 4, 
12, and 18 nm in diameter and capped with different agents showed non-toxic effect to 
human leukemia cell line105. Another group obtained similar results in cytotoxic study on 
influence of 3.5 nm onto immune system cell lines106. Citrate capped gold nanoparticles 
didn’t show cytotoxic effects on dendritic cells, nor changed their phenotype107. On 
contrary, Goodman et al. found that cationic gold nanospheres of 2 nm diameter induced 
toxic effect on COS-1 cells at concentrations of 0.38-3 μM after 24 h incubation, while 
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the same nanoparticles with negative charge didn’t. These results were explained through 
electrostatic interaction of cationic nanoparticles with negatively charged cell 
membrane108. Pan et al. investigated how nanoparticle size affects cytotoxicity in HeLa, 
SK-Mel-28 (melanoma cell line), L929 (mouse fibroblast cell line) and j774A1 
(macrophage cell line) cell lines. In this study they found that 1.4 nm gold nanospheres 
(up to 5.6 μM after 72h incubation) induced cell necrosis, oxidative stress and 
mitochondrial damage in all cell lines. These effects weren’t seen in the case of 15 nm 
diameter nanospheres109,110. Further it was concluded through studies of Patra et al. that 
some citrate capped gold nanoparticles were found toxic to a human lung carcinoma 
cells, but not to a human liver carcinoma cells111. Asharani et al. compared cytotoxicity 
of silver (5-35nm), gold (15-35nm) and platinum (3-10nm) nanoparticles capped by 
polyvinyl alcohol (PVA) on developing zebra fish embryos112. Gold nanoparticles had the 
least toxic effect in this study, not influencing hatching, mortality or cardiovascular 
system functioning. In study on effect of gold nanoparticle shape and surface 
functionalization onto epithelial cells, it was found that with the same functionalized 
group (coated with CTAB) rod shaped nanoparticles were less toxic than spherical 
ones113. The higher toxicity of gold nanospheres was attributed due to the higher CTAB 
translocation upon entering the cell compared to nanorods. These results suggest that cell 
type-nanoparticle specific interactions play the roll in toxicity 
 Silver nanoparticles (20 and 40 nm functionalized with small peptide) were found 
to cause toxicity in THP-1-derived human macrophages114. Smaller size NPs were more 
toxic compared to larger ones and after 48 h sharp decrease in cell viability was observed 
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at 18 μg/ml concentration of 20 nm AgNPs and 30 μg/ml concentration of 40 nm AgNPs. 
Nanoparticles were efficiently taken by macrophages where they exerted oxidative stress 
and through reactive oxidative species (ROS) damaged the cell. Other study of 10 nm 
AgNP with different coatings (citrate, PVP) caused DNA damage in human lung cells115. 
A lot of carried studies identified AgNP as a potential source of cytotoxicity116–120.  
 Cytotoxicity of carbon nanomaterials was observed as well. Pulmonary toxicity of 
single-walled carbon nanotubes induced lethargy, weight loss and death in mice121. 
Similarly, multiwalled carbon nanotubes induced mesothelioma in mice122. Studies on 
graphene oxide discovered it’s toxicity onto different cell lines123. Also depending on the 
hydroxylation, pristine and hydroxyl functionalized fullerenes exhibited toxic effect onto 
human dermal fibroblast and human liver carcinoma cells124. While pristine fullerenes 
exerted oxidative stress onto the cell and induced cell necrosis, hydroxylated fullerenes 
triggered cell apoptosis.  
 Also, recently it was found that nanoparticles interfere with protein aggregation. 
Formation of protein aggregates is considered to lead to Alzheimer’s, Huntington’s, 
Parkinson’s, Creutzfeldt-Jacobs (mad cow) disease125–127. Depending on the type of 
nanoparticle and protein involved, it was found that some nanoparticles promote, while 
other hinder protein aggregation128–134, leading to possible application of nanomaterials in 





4. Understanding interactions of nanoparticles with environmental and biological 
system using both experimental and computational approaches.  
Understanding the protein corona formation and transformation through nanoparticle-
protein interaction is of the crucial importance in order to predict the fate of 
nanomaterials in biological systems. My research predominantly focused onto the study 
of protein corona genesis and its implications onto the protein structure and binding 
dynamics. My first study, presented in Chapter 2, delineated physical properties of 
fibrinogen protein corona on single-walled and multiwalled nanotubes. It identified 
distinct morphology of protein corona on SWCNT and MWCNT. Further, it investigated 
the interaction of protein corona with HT-29 cell’s membrane and itss translocation upon 
the nanoparticle internalization into the cell.  Although, this and the other experimental 
studies provided insights on formation, and size of protein corona135, and protein 
composition on the nanoparticle surface136, due to limited instrumental resolution, the 
molecular details of protein-nanoparticle interaction are poorly understood. Utilizing 
computational modeling together with the experiment, my research will try to bridge the 
gap between experimental observations and the molecular systems of the interest.  
Traditional molecular dynamics approaches already can accurately describe the system of 
proteins and nanoparticles137–140, but lack reaching the timescales necessary for 
description of large systems141,142. This obstacle can be surpassed by employing coarse 
grained models and using simplified force fields143–148, but they have limited predictive 
power on studying interactions between nanoparticles and specific protein. 
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 In Chapter 3 we performed molecular dynamics study on formation of ubiquitin-
silver nanoparticle protein corona. There we showed that our modeling can capture and 
reach length scales necessary for protein corona formation with high agreement to 
experimental studies. Further, study on ubiquitin-fullerene derivatives corona is outlined 
in Chapter 4 with emphasis on influence of nanoparticle surface chemistry on specific 
binding and protein misfolding. Studies in Chapter 3 and Chapter 4 investigated systems 
with one kind of protein, while in Chapter 5, I investigated protein corona evolution when 
different biomolecules compete on the nanoparticle surface. Finally, effects of 
nanoparticle surface on protein aggregation will be described in Chapter 6, specifically 
focusing on protein aggregation on nanoparticle surface and its implications onto the 








FORMATION AND CELL TRANSLOCATION OF FIBRINOGEN-CARBON 
NANOTUBES CORONA 
Chen R; Radic, S et al. Formation and cell translocation of carbon-fibrinogen protein 
corona. Appl Phys Lett., 101(13), 133702. Reproduced in part with permission of 
American Institute of Physics. 
1. Introduction 
 Carbon-based nanomaterials have been studied extensively over the past two 
decades for their unique physical properties and vast potential in electronics, imaging, 
sensing, biotechnology, and environmental remediation. Carbon nanotubes (CNTs), a 
major class of carbon-based nanomaterials, are especially attractive for biological and 
medicinal applications owing to their large surface area, high aspect ratio, and simplicity 
for accommodating chemical groups and drug loads149. However, integrating carbon 
nanomaterials with biological systems must first address the inherently poor solubility 
and biocompatibility of the engineered materials, on molecular, cellular and whole 
organism levels135,150. 
 The solubility and biocompatibility of carbon-based nanomaterials may be 
afforded or enhanced through specific surface functionalization or nonspecific adsorption 
of proteins, lipids, amino acids, and nucleic acids151–155. Alternatively to such purposeful 
surface modifications, nanoparticles (NPs) voluntarily assume the form of a NP-protein 
“corona” upon entering living systems156, resulting from their surface adsorption by 
plasma proteins and other biomolecular species. Naturally, understanding the formation 
of NP-protein corona has become a focused area of study due to its great relevance to 
26 
 
delineating the fate and toxicity as well as facilitating the biological and medicinal 
applications of nanomaterials157.  
 The currently accepted paradigm assumes that the formation of NP-protein corona 
depends upon the physicochemical properties of the NPs (surface charge, coating, shape, 
roughness, and reactivity), the solvent (pH, ionic strength, and temperature), and the 
proteins (amphiphilicity, charge, pKa, chemical composition, and folding dynamics)157–
159. In addition, plasma proteins may exhibit short (“soft”) or long-term (“hard”) 
residence times on their NP substrates101, derived from the cooperativity (the Vroman 
effect160, folding/unfolding) between the proteins convolved with the protein affinity for 
the NP substrates mediated by electrostatic and hydrophobic interactions, van der Waals 
forces, and hydrogen bonding.      
 In consideration of the vast biological and medicinal potentials of carbon-based 
nanomaterials, we have examined in the current study the binding of both single-walled 
and multiwalled CNTs (SWCNTs and MWCNTs) with fibrinogen (FBI), a major class of 
plasma glycoprotein that is essential for the coagulation of blood. It is shown through this 
study that the formation and stability of CNT-FBI coronas correlate with the differential 
surface areas of the two types of CNTs, as indicated by our UV-vis spectrophotometry 
and electron and fluorescence measurements. In addition, we have determined that the 
binding of fluorescently labeled FBI onto CNTs induced static (and possibly dark) 
quenching of the protein fluorescence. Utilizing the energy transfer between labeled FBI 
and CNTs (Fig. 4.1, left panel scheme), we have shown that CNT-FBI coronas could 
dissociate upon cell translocation, likely as a result of the different affinities of the 
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proteins and the nanostructures for the membrane bilayers. The knowledge derived from 
this biophysical study complements the existing proteomic, thermodynamic, and 
chromatographic studies of NP-protein corona101,136,157,159,161,162, and may benefit both in 
vitro and in vivo evaluations of biological responses to intentionally administered or 
accidentally released nanomaterials.   
 SWCNTs (diameter: 1.4 nm, length: 0.5-3 µm, 5% impurities) and MWCNTs 
(OD: 40-70 nm, ID: 5-40 nm, length: 0.5-2 µm) were purchased from Carbon 
Nanotechnologies and Sigma. Bovine plasma FBI (termed as “unlabeled FBI”, MW: 
330kDa) and Alexa Fluor 546-labeled human plasma FBI (termed as “labeled FBI”, ~15 
dyes per FBI, Ex/Em: 558/573 nm) were received from Sigma and Invitrogen. The 
surface areas of SWCNTs and MWCNTs (in powder form) were derived from the 
Brunauer-Emmett-Teller (BET) equation163 and the Barrett-Joyner-Halenda (BJH) 
method164 as 855 and 104 m2/g, respectively, using a physisorption analyzer 
(Micromeritics ASAP 2010). 
 
2. Results and Discussion 
 The formation of CNT-FBI coronas was first visualized by scanning electron 
microscopy (SEM) imaging (Fig. 5.1, right panels). Specifically, CNTs and unlabeled 
FBI were mixed with Milli-Q water to final concentrations of 0.3 and 0.4 mg/mL 
respectively and incubated overnight. The CNT-FBI samples were then deposited onto 
aluminum substrates and air-dried. A Hummer 6.2 (Anatech) sputter was used to pre-coat 
the samples with a 2-4 nm layer of platinum for 1 min (pressure: 80 milli-torr, voltage: 15 
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mA). SEM imaging of the CNT-FBI protein coronas was then performed using a Hitachi 
S4800 electron microscope, at accelerating voltages of 10-15 kV. FBI coated both the 
SWCNTs and MWCNTs fully, and especially in the case of MWCNTs the protein 
agglomeration on the nanotube surfaces appeared complex in morphology. This is likely 
due to the bundling of the SWCNTs (Fig. 5.1, SWCNTs control), whose surface 
roughness and grooves could promote the predominantly axial orientations of the tubular 
FBI. In comparison, the larger and flatter MWCNT surfaces should be less restrictive for 
the binding of the protein.     
 
Figure 5.1. Fibrinogen corona. (Left panel) Schematic of the present study, showing quenching 
of FBI fluorescence as a result of energy transfer from the proteins to their CNT substrate and 
translocation of CNT-FBI across a cell membrane. (Right panel) SEM images of SWCNT 
bundles, SWCNT-FBI coronas (top panels), MWCNTs, and MWCNT-FBI coronas (bottom 




 The stabilities of the CNT-FBI coronas were characterized by a Cary 300 BIO 
spectrophotometer (Varian). SWCNTs and MWCNTs were mixed separately with 
unlabeled FBI in Milli-Q water (pH 6.5) to render final concentrations of 0.5 mg/mL for 
both types of the CNTs and 2.5 mg/mL for the protein, respectively. The absorbance of 
the CNT-FBI mixtures was measured at 280 nm, corresponding to the wavelength where 
the tryptophan residues in FBI exhibited a peak absorbance. The absorbance 
measurement was conducted for 10 h, at a time interval of 30 min. As shown in Fig. 5.2 
a, the absorbance dropped exponentially until stabilized after ~400 min for the SWCNT-
FBI sample, while it remained very stable for the MWCNT-FBI sample over the entire 
course of 10 h. This result suggests that the SWCNT-FBI coronas were “softer” than the 
MWCNT-FBI, a proposition also corroborated by our analysis below. In addition to van 
der Waals force, hydrophobic interaction, as well as pi-stacking which could underlie the 
formation of CNT-FBI coronas, FBI could also initiate hydrogen bonding between 
adjacent CNT-FBI coronas. In the case of SWCNTs such inter-corona interaction could 
further destabilize the protein coating to induce precipitation. 
 The two different trends of protein absorbance in Fig. 5.2a can be analyzed using 
















, where c is 
concentration of the solute (i.e., the CNT-FBI corona), D and s are the solute diffusion 
constant and sedimentation coefficient, z is a length parameter, and g is the acceleration 
of gravity. Based on the fitted exponents of -0.007 (for SWCNTs) and 0 (for MWCNTs) 
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in Fig. 5.2 a, the value of 4D/(sg)2 was calculated as 136.7 min for SWCNTs and infinity 
for MWCNTs. Assuming m0 and mb are the actual and buoyant mass of the solute, ρf and 
ρ0 the densities of the solute and water, kb the Boltzmann constant, and T the temperature, 
and evoking equations 
)/( 00 1 ρρ fb mm −=  and TkmDs bb // =  derived from the Einstein 
relation we estimate that SWCNT-FBI possessed an effective density of 1.36 g/cm3 while 
MWCNT-FBI assumed an effective density approximately equal to that of water. Since 
the density of SWCNTs is ~1.4 times that of water166 and is only slightly higher than that 
of SWCNT-FBI, we conclude that SWCNT bundles were coated with thin layers of FBI 
to elicit a poor stability in water. In contrast, our analysis implies that MWCNTs were 
adsorbed with multilayers of the protein to render a hard corona.    
 Fluorescence spectroscopy was utilized to yield more insight on the binding of 
CNTs and FBI. Specifically, 3 mg of SWCNTs and MWCNTs were each added to 3 mL 
of Milli-Q water and bath sonicated for 1 h. The CNTs were then mixed individually with 
66.7 μL of the labeled-FBI (1.5 mg/mL) and Milli-Q water to yield samples containing 
10-80 μg/mL of SWCNTs, 100-800 μg/mL of MWCNTs, and 100 μg/mL of labeled FBI. 
The CNT-labeled FBI samples were then bath sonicated (Precision, Thermo) for 15 min 
and incubated for 1 h on a rotator. After that the CNT-labeled FBI mixtures were 
centrifuged at 12,100 RCF (13,400 RPM) for 15 min and supernatants containing free, 
labeled FBI molecules were collected. Fluorescence intensities (Ex/Em: 558 nm/565-585 




Figure 5.2. Spectroscopic characterization of FBI corona. (a) Normalized absorbance curves 
showing the stability of CNT-FBI coronas for both SWCNTs (blue diamonds) and MWCNTs 
(red circles) over 10 h. (b) Fluorescence intensities of free, labeled FBI supernatants obtained 
from pelleting SWCNT-FBI (blue curves, 10, 40, and 80 μg/mL of the SWCNTs) and MWCNT-
FBI coronas (red curves, 100, 400, and 800 μg/mL of the MWCNTs). The fluorescence 
intensities decreased with increased nanotube concentration for both samples. (c) Stern-Volmer 
plots show quenching coefficients of 32.7 and 8.8 for SWCNT-FBI and MWCNT-FBI coronas, 
respectively. I0 and If: fluorescence intensities of the labeled FBI control and the CNT-labeled 
FBI mixture, respectively. CNT concentrations: 0.02 to 0.08 mg/mL.       
 Compared with the control, the fluorescence intensities of all CNT-labeled FBI 
samples decreased (Fig. 5.2 b) as a result of CNT-FBI corona formation. Such 
fluorescence quenching can be attributed to the energy transfer between the labeled FBI 
(donor) upon excitation and the CNTs (acceptor) upon their binding with the proteins. 
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This energy transfer was efficient for SWCNTs because their second van Hove 
absorption transitions (i.e., 500-900 nm)167,168 coincided with the emission of the Alexa 
Fluor 546 dye. Based on geometrical argument and our surface area measurement, the 
adsorbing capability of SWCNTs was estimated as one order of magnitude higher than 
that of MWCNTs per unit mass. Indeed, the fluorescence intensities were comparable 
between SWCNT and the 10× more concentrated MWCNT samples, showing a good 
correlation between protein adsorption capacity and surface area of the CNTs. 
The peak fluorescence intensities at 572 nm were plotted for the CNT-labeled FBI 
samples and fitted using the Stern-Volmer equation: I0/If = 1 + KSV[CNT], here I0 and If 
are the fluorescence intensities of the labeled FBI (control) and CNT-labeled FBI mixture 
respectively, KSV is the Stern-Volmer quenching coefficient, and [CNT] is the 
concentration of the nanotubes. The Stern-Volmer plots appeared linear for both 
SWCNT-FBI and MWCNT-FBI samples at lower CNT concentrations (first 4 data points 
in Fig. 5.2 c), indicating a single quenching mechanism. At higher CNT concentrations, 
however, both curves deviated from linearity to denote occurrence of additional 
quenching mechanisms. Since collision between CNTs and FBI should occur more 
frequently at high concentrations the linear Stern-Volmer plots at the low CNT 
concentrations were attributed to static quenching. Though not substantiated in this study 
CNTs may also absorb light analogously to blackbody169. In our experiment, the molar 
mass ratio of the SWCNTs to MWCNTs was 1:418, and therefore the ratio of the Stern-
Volmer coefficients for the SWCNT-FBI and MWCNT-FBI samples was 
32.7:(8.8×418)=1:112. This analysis revealed that MWCNTs were far more efficient 
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quenchers than SWCNTs, whose smaller diameter and greater curvature were less 
favorable for the adsorption and alignment of the tubular FBI molecules. 
 The fluorescence quenching upon corona formation was utilized to examine the 
stability of CNT-FBI in vitro. For this purpose, HT-29 human colonic adenocarcinoma 
cell lines were cultured in DMEM with 1% penicillin streptomycin, 1% sodium pyruvate, 
and 10% fetal bovine serum. Approximately 5,000 cells were seeded in each well of a 
chambered glass slide and allowed to attach overnight at 37°C with 5% CO2. The culture 
medium was then replaced with phosphate buffered saline (PBS) and CNTs coated with 
purified labeled FBI (free proteins removed by centrifugation) and added in each well to 
obtain concentrations of 1.25 and 12.5 μg/mL for the SWCNTs and the MWCNTs, 
respectively. This mass concentration ratio of 1:10 was to ensure the same amount of 
labeled FBI coated on the two types of nanotubes. The CNT-FBI coronas were allowed to 
incubate with cells for 2 h, followed by washing and replacing with fresh PBS prior to 
imaging. 
 As shown in Fig. 5.3, the FBI fluorescence is largely quenched in both panels (c) 
and (d), indicating CNT-FBI corona formation for both SWCNTs and MWCNTs. Cell 
adsorption of SWCNT-FBI and fluorescence recovery of FBI in intracellular space were 
evident (Fig. 5.3 e, arrows), suggesting dissociation of SWCNTs and FBI post membrane 
translocation. The isoelectric point of FBI is 5.5170, and therefore the proteins were 
slightly positively charged when stored/processed in endosomes and lysosomes (~pH 4.5) 
and slightly negatively charged when located in cytosol (~pH 7.2). Since the SWCNT 
surfaces were charge neutral, changes in pH in the intra- and extracellular environment 
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should not drastically impact the binding of SWCNT-FBI. The dissociation of SWCNTs 
and FBI is therefore attributed to their differential affinities for the amphiphilic cell 
membranes.          
 Pronounced cell adsorption of MWCNT-FBI and recovery of FBI fluorescence in 
the extracellular space were observed, but minimal fluorescence was seen in the 
intracellular space perhaps due to the high energy cost for MWCNT endocytosis (Fig. 5.3 
f). In addition, cell damage (from elongated to round shapes) was more apparent for 
MWCNTs than SWCNTs (Figs. 5.3 f vs. 5.3 e), likely due to the higher dosage and the 
toxicity associated with the MWCNTs171. 
 
Figure 5.3. HT-29 cell uptake of CNT-FBI coronas overlaid from bright field and confocal 
fluorescence images. (a, b) Controls of labeled FBI fluorescence and HT-29 cells. (c, d) Controls 
of SWCNT-FBI and MWCNT-FBI showing fluorescence quenching. (e) Cell adsorption of 
SWCNT-FBI and FBI fluorescence recovery in the intracellular space (arrows). (f) Pronounced 
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cell adsorption and dissociation of MWCNT-FBI in the extracellular space indicated by 




 In short, we have examined the formation and stability of CNT-FBI coronas in the 
aqueous phase and in vitro. The binding between CNTs and FBI is consistent with the 
high hydrophobic and aromatic moieties of both the protein and the nanotubes, and 
agrees with the in sillico studies involving similar systems172–174. The differential 
“hardness” and stability of the SWCNT-FBI and MWCNT-FBI coronas were analyzed 
based on the concept of buoyant mass and Stern-Volmer plots, and were attributed to the 
different surface areas and morphology of the two types of CNTs. This study offers a new 
biophysical perspective for elucidating the concept of NP-protein corona, a topic essential 
to our understanding of the implications and applications of nanomaterials in living 





CONCEPT OF DICRETE MOLECULAR DYNAMICS SIMULATIONS IN 
STUDYING PROTEIN CORONA PHENOMENA 
Ding, F; Radic, S et al. Direct Observation of a single nanoparticle-ubiquitin corona formation. 
Nanoscale, 2013, 5, 9162. Reproduced in part with permission of The Royal Chemical Society. 
1. Intoduction 
 Nanomaterials have been increasingly applied in consumer products due to their 
unique physical and chemical properties as stated in Chapter 1. Recently, protein corona 
has been found to screen functionalized molecules conjugated to nanoparticles, and 
subsequently cause the loss of designed function175. In addition, interactions with 
nanoparticles can also alter the structure, dynamics, and function of the bound proteins, 
which could further impact recognition of the proteins by membrane receptors and the 
immune system. Previous experimental studies have provided much insight, such as the 
existence and size of the protein corona135, and protein composition on the nanoparticle 
surface136. However, due to limitations in instrument resolution, the molecular detail of 
protein-nanoparticle interaction remains poorly understood. Computational modeling, in 
contrast, provides a useful approach to bridge the gap between experimental observations 
and the molecular systems of interest176. Here we performed both computational and 
experimental characterizations of protein corona formation between a silver nanoparticle 
(AgNP) and ubiquitin protein. Silver nanoparticles are widely used in commercial 
products for their antibacterial and antifungal properties177, while ubiquitin is 
ubiquitously expressed in all eukaryotic cells regulating protein distribution and 
recycling, thereby making AgNP and ubiquitin a representative model system for 
studying nanoparticle-protein interaction and corona formation.  
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 Two major challenges arise in computational modeling of protein corona. First is 
the large system size — where an abundance of proteins interacts with nanometer-sized 
nanoparticles, and second is the long timescales associated with protein corona 
formation. Traditional molecular dynamics approaches can accurately describe the 
molecular system of nanoparticles and proteins137–140, but are not able to reach the 
relevant time and length scales needed for depicting large systems till equilibration141,142. 
In comparison, coarse-grained simulations143 can be used to study large molecular 
systems and reach long time scales by using a simplified forcefield144. These coarse-
grained simulations have been applied to study general aspects of NP-protein 
interactions143,145–148, but have limited predictive power for studying NP interactions with 
specific proteins. To overcome this barrier, we adopted a multiscale modeling 
approach178, which coherently blended atomistic and coarse-grained simulations179,180. 
All-atom simulations were first performed to investigate the possible binding modes 
between an individual ubiquitin and a AgNP, and the knowledge of AgNP-ubiquitin 
binding was then incorporated into the construction of a coarse-grained model. With the 
coarse-grained simulations, we were able to extensively characterise the structure and 
dynamics of AgNP interacting with multiple ubiquitin molecules (up to 50). The 
dynamics of both atomistic and coarse-grained models were sampled by discrete 
molecular dynamics (DMD)181, an efficient sampling method for underpinning protein 





2. Results and Discussion 
 Our transmission electron microscopy (TEM) and UV-vis absorbance 
measurements (Experimental Section, Appendix A) confirmed the binding of ubiquitin 
and citrate-coated AgNP (Figs. 2.1 a,b). For UV-vis, specifically, a red-shift occurred 
from 393 nm (peak wavelength for AgNP absorbance) to 407 nm (peak wavelength for 
AgNP-ubiquitin absorbance), indicating an increased dielectric constant resulting from 
nanoparticle-protein complex formation. Consistently, our dynamic light scattering 
measurement (Fig. Appendix A1) showed a hydrodynamic size of 34.5 nm for AgNP-
ubiquitin at molar ratios of 1:100 to 1:500 (zeta potential: 12.3 mV), compared to that of 
4.8 nm for ubiquitins (zeta potential: 4.6 mV) and 13.6 nm for AgNPs (zeta potential: -
45.0 mV) alone, further corroborating their effective binding.  
 
Figure 3.1. Interaction between a single ubiquitin and a citrate-coated AgNP. (a) TEM 
images of AgNPs (left panel) and AgNP-ubiquitin coronas (right panel) where the associations of 
the AgNPs and the proteins (shaded regions) are evident to imply their good binding affinity. (b) 
39 
 
UV-vis absorbance of AgNP, ubiquitin, and AgNP-ubiquitin, featuring a red-shift of the 
absorbance peaks for AgNP-ubiquitin and AgNP alone due to dampened surface plasmon 
resonance. (c) Initial (t = 0 ns) and final (t = 50 ns) structure of the ubiquitin-citrate-AgNP 
complex system. The ubiquitin is represented as cartoons, the side chains as lines, and the citrates 
as sticks. The gray sphere represents the nanoparticle, and the charged atoms on the AgNP 
surface are shown as blue spheres. Zoom-in view of the final structure indicates the binding 
between the ubiquitin and a charged AgNP surface atom. (d) The negatively (aspartate and 
glutamate) and positively (lysine and arginine) charged residues in ubiquitin are shown as sticks 
(left panel). The surface electrostatic potential (computed using PyMol, www.pymol.org) 
illustrates the cluster of negatively charged atoms near the protein helix (right panel). (e) 
Distributions of citrates around AgNP (solid lines) derived from the simulations. The electrostatic 
(ES) interaction between citrate and AgNP was artificially enhanced in one case. The dashed 
lines correspond to the accumulative probability. The horizontal dashed line corresponds to 
charge saturation, where the total charge of citrates equal that of the AgNP. 
 
 Next, we performed multiscale simulations to characterize the nanoparticle-
ubiquitin corona formation in silico. We first performed atomistic simulations of a 
molecular system comprised of one ubiquitin molecule and one citrate-coated AgNP 
(Appendix A). The simulations were performed with implicit solvent, and the inter-
atomic interactions were modeled by a physical force field adapted from Medusa182, 
which include van der Waals, solvation183, electrostatic, and hydrogen bond potentials. 
The coarse-grained silver atoms of the AgNP were assigned as hydrophobic with a small 
fraction being positively charged to account for the nanoparticle surface charges184. 
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During simulations, we kept the center of the AgNP static, while allowing the ubiquitin 
and the citrates to move freely in the simulation box and surface silver atoms mobile on 
the NP surface. Since the physical properties of the coarse-grained AgNP model are 
rather general, the observed behaviors of AgNP-ubiquitin binding should be readily 
applicable to other metallic nanoparticles with positive surface charges, such as gold 
nanoparticles (AuNPs). 
 To evaluate whether ubiquitin could bind to a citrate-coated AgNP, we performed 
DMD simulations at 300 K with a ubiquitin molecule initially positioned away from a 
citrate-coated AgNP (Fig 4.1 c).  Interestingly, we found that the neutral ubiquitin did not 
bind to the hydrophobic surface of the AgNP, but instead attracted to the surface charge 
of the AgNP by replacing the surface-bound citrates (-3e at neutral pH) that were 
stabilized by electrostatic interactions (Fig 4.1 c). Although ubiquitin does not have a net 
charge, it does possess eleven positively-charged and eleven negatively-charged residues 
out of the 76 total residues185. Near the surface of the ubiquitin helix, negatively-charged 
residues formed a cluster with low electrostatic potentials (Fig 4.1 d), which favored 
electrostatic interaction with counter charges186. The local surface area with low 
electrostatic potential allowed a stronger binding to the AgNP in simulations than did the 
negatively-charged citrates.  
 To test whether electrostatic interaction was the driving force for AgNP-ubiquitin 
binding, we artificially enhanced the binding affinity between citrates and AgNP by 
adding an additional charge to the citrate molecule (Appendix A). For both the case of 
artificially-enhanced electrostatic interactions and the regular (non-enhanced) case, we 
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performed ten independent atomistic DMD simulations with different initial 
AgNP/ubiquitin configurations. For a higher citrate-AgNP affinity due to enhanced 
electrostatic interactions, we did not observe any AgNP-ubiquitin binding in all 
simulations. In the case of regular citrate-AgNP interactions, we observed AgNP-
ubiquitin binding for seven out of the ten simulations. The computed distributions of 
citrates from the AgNP also illustrated that the ability for ubiquitin to displace citrates 
and bind AgNP depended upon the electrostatic-dominating affinity between the citrates 
and the AgNP (Fig. 3.1 e). Therefore, the binding of ubiquitin to AgNP was mainly 
determined by electrostatic interactions. 
 From independent atomistic simulations, we constructed a structural ensemble of 
AgNP-ubiquitin binding complex. We averaged over the ensemble to compute for each 
residue the probability of forming contact with the AgNP, PAgNP, (Appendix A). Only a 
subset of protein residues showed significantly high contact frequencies, while the rest of 
the protein did not interact with the AgNP (Fig. 3.2 a). As the result, the histogram of 
PAgNP featured a bimodal distribution, with one peak close to zero and the other centered 
around PAgNP ~ 0.4 (Fig. 3.2 b). We further determined the AgNP-binding residues (Fig. 
3.2 b insert) as those with PAgNP larger than 0.3, the median value separating two peaks in 
the histogram. These residues were located near the protein helix (Fig. 3.1 d). Although 
electrostatic interaction was indentified as the driving force for AgNP-ubiquitin binding, 
intriguingly only a fraction of the negatively-charged residues had high contact 
frequencies with the positively-charged AgNP surface (Figure 3.2 a). Since these 
negatively-charged residues are scattered on the surface of ubiquitin (Figure 3.1 c), it was 
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unknown a priori where these AgNP-binding residues were located. Next, we compared 
our results with a nuclear magnetic resonance (NMR) study of ubiquitin-gold 
nanoparticle (AuNP) binding187. In the NMR study, chemical shift of backbone NH 
groups was monitored upon ubiquitin binding to the AuNP. Since NMR chemical shift is 
very sensitive to the corresponding environment, chemical shift perturbations could be  
caused either by direct binding with the AuNP or due to NP-binding induced 
conformational changes. Three residues — 2, 15, and 18 — were found to have 
significant chemical shift perturbations upon binding to the AuNP. These residues are 
close to each other in the 3D structure, suggesting that the corresponding surface area 
bound to the AuNP. In our simulations, residue 18 had a high contact frequency with the 
AgNP and residue 2 also formed contact with AgNP (Fig. 3.2 a). The reason that we did 
not observe residue 15 in contact with the AgNP is due to the fact that leucine 15 is 
buried inside the protein. Since AgNP and AuNP are comparable both physically and 
chemically, we believe that the modes of their binding with ubiquitin are also 
comparable. This agreement between NMR observations and simulations highlights the 
predictive power of our computational methods.  
We further investigated the thermodynamics of AgNP-ubiquitin binding by computing 
the potential of mean force, PMF (Appendix A). We calculated the 2D-PMF with respect 
to the centre-of-mass distance between AgNP and ubiquitin, dcm, and the number of 
contacts between AgNP and the residues identified to bind AgNP specifically, Nc (Fig. 3.3 
a). The 2D-PMF plot has two minima. One minimum corresponds to non-specific 




Figure 3.2. Specific binding between ubiquitin and AgNP. (a) The contact probability between 
AgNP and each ubiquitin residue, computed from independent all-atom DMD simulations 
(Appendix A). The shaded regions correspond to negatively charged residues, including both 
aspartate (Asp) and glutamate (Glu). (b) The histogram of the AgNP-ubiquitin contact probability 
displays a bimodal distribution. The ubiquitin residues with high contact frequency (> 0.3; 
corresponding to the second peak) to the AgNP are shown in sticks (insert). The residue Asp18 
was also found to interact with gold nanoparticles187. 
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the specific binding with Nc > 0 and dcm < 70 Å. The barrier separating two minima 
corresponds to the re-orientation of the protein as illustrated in a typical simulation 
trajectory (Fig. 3.3 b). Before specific binding (t < 0.7x106 t.u.), the system featured a 
large fluctuation of dcm with the protein near the AgNP surface (dcm ~ 70 Å). The protein 
had similar root-mean-square deviation (RMSD) from its native state before and after 
specific binding to AgNP. Therefore, protein re-orientation on the surface of AgNP was 
the rate-limiting step toward the specific binding. 
 In order to observe the formation of AgNP-ubiquitin corona in silico, it is 
necessary to include multiple proteins in simulations, which is beyond the capacity of 
atomistic simulations. Instead, we used a two-bead-per-residue model188 to represent 
ubiquitin and a single atom to model each citrate. The inter- and intra-ubiquitin 
interactions were modeled by a structure-based potential model189,190 which has been 
extensively used in computational studies of protein folding and protein aggregation180. 
The specific interactions between the AgNP surface charges and ubiquitin residues as 
well as other non-specific inter-molecule interactions were modeled according to 
atomistic DMD simulations (Appendix A). 
 We investigated AgNP-ubiquitin corona formation by performing DMD 
simulations of the coarse-grained system, with multiple ubiquitins (25 molecules) 
initially positioned randomly with respect to a citrate-coated AgNP. The temperature of 
the simulation system was kept at 325 K, which is below the melting temperature of 




 Figure 3.3. AgNP-ubiquitin binding thermodynamics. (A) Contour plot of the 2D-PMF with 
respect to inter-molecule distance, dcm, and the number of specific inter-molecule contacts, Nc. 
The unit of PMF is kcal/mol. (B) A typical trajectory of the all-atom simulation of AgNP-
ubiquitin binding. Nc, dcm, and the RMSD of ubiquitin are shown as functions of the simulation 




Therefore, an isolated protein was thermodynamically stable, mimicking the 
physiological conditions where the protein remains folded. To avoid potential biases 
associated with initial conditions, we performed ten independent simulations assuming 
different initial configurations and velocities. For each simulation we monitored the 
number of ubiquitins directly bound to the surface of AgNP, Nbound, as a function of time. 
All trajectories in Fig. 4a featured an initial fast binding, which slowed down as time 
progressed. Interestingly, the average Nbound did not follow a typical single-exponential 
binding kinetics, ~ 1-exp(-λt), which usually features a power-law with the exponent of 1 
during initial binding in a log-log plot (Fig. 3.4 b). Instead, the exponent is ~0.21 < 1. 
Fitting analysis (Appendix A) suggested that a stretched-exponential, ~ 1-exp(-ctα), better 
represented the kinetics data. Similar stretched-exponential binding kinetics has been 
reported for the adsorption of human serum albumin onto a colloidal nanoparticle191. A 
stretched exponential function, corresponding to a linear superposition of exponential 
decays with a continuous distribution of relaxation times, is often used to describe the 
relaxation kinetics with high heterogeneity in the relaxation time. The heterogeneity 
could originate from competition with citrates, depletion of available binding sites for 
incoming ubiquitins, and non-specific interactions with other proteins. The binding rate 
between citrate and AgNP was concentration-dependent, and increased as ubiquitins 
displaced AgNP-bound citrates and subsequently increased the citrate concentration in 
solution. Examination of the simulation trajectories also suggested non-specific binding 
between the incoming protein and the proteins already bound to the surface, which 
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slowed down the specific binding with NP (Fig. A3). All these factors hindered the 
binding of ubiquitins to the AgNP surface, leading to the stretched exponential binding 
kinetics. 
 A stretched exponential decay of protein concentration in solution, [p]~exp(-ctα) 
with α<1, suggests that the association rate, –(d[p]/dt)/[p] ~ 1/t1-α decreased as time 
increased and as more proteins bound to the NP surface. Assuming that the dissociation 
rates were the same for all proteins, the binding constant decreased as more proteins 
bound to the NP surface, which is indicative of the lack of binding cooperativity among 
the proteins. This observed anti-cooperativity is possibly a result of both steric 
hindrance191 and non-specific protein-protein interactions (Fig. A3). Therefore, our 
coarse-grained simulations revealed a rich kinetics for nanoparticle-protein binding, 
which may need to be considered in future kinetic and mesoscopic modeling of corona 
formation, such as studies of the Vroman effect of abundant proteins for a nanoparticle 
entering the bloodstream160. 
 The AgNP-ubiquitin complex structure derived from simulations had multiple 
ubiquitins bound to the surface of one AgNP, forming a single-layer protein corona (Fig. 
3.4 c). The majority of AgNP-bound proteins stayed folded under the particular 
simulation condition (Appendix A) and bound to the surface of the AgNP with the 
protein helix facing the nanoparticle. Only in one of the simulations, one ubiquitin out of 
the 22 AgNP-bound proteins partially unfolded and the conformation was stabilized by 
extensive contacts with the hydrophobic surface of the AgNP (Fig. 3.4 c). In addition, we 
explored the effect of protein concentration on corona formation by performing DMD 
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simulation for a higher ubiquitin/AgNP stoichiometry of 50:1. In these simulations, 
ubiquitins competed with citrates for binding to the AgNP (Fig. 3.4 d). The final structure 
featured multiple layers of protein corona, whereas the first layer was dominated by 
specific binding between ubiquitins and the AgNP, and the outer layers were stabilized 
by protein-protein interactions (Fig. 3.4 e). This observation is consistent with our 
dynamic light scattering measurement (Fig. A1), where the hydrodynamic size of AgNP-
ubiquitin was increased from ~35 nm at AgNP:ubiquitin ratios of 1:100 and 1:500 to 44 
nm and 52 nm at AgNP:ubiquitin ratios of 1:1,000 and 1:2,000, respectively. Hence, the 
AgNP-ubiquitin complex structures derived from the coarse-grained simulations 
successfully revealed an atomic picture of the nanoparticle-protein corona.  
 The ability of nanoparticles to induce protein unfolding in the corona (Fig. 3.4 c) 
could be one of the mechanisms of nanotoxicity. To evaluate the impact of AgNP-
binding on ubiquitin conformation, we computed for each protein residue the fraction of 
native contacts (Q-value192) for both the AgNP-bound and unbound ubiquitins (Fig. 3.5 
a). A residue with its Q-value close to 1 maintains a native-like structure, while losing its 
structure if the Q-value is near 0. Both the AgNP-bound and unbound ubiquitins 
maintained native-like structures with most regions having their Q-values close to 1. 
Only loop regions between the secondary structures (18-19, 32-35, and 46-53) had 
relatively low Q-values. The difference in the Q-values for AgNP-bound and unbound 
ubiquitins suggests that residues in contact with the AgNP were stabilized upon binding 




Figure 3.4. Ubiquitin-AgNP corona formation. (a) The number of ubiquitin molecules bound 
to AgNP, Nbound, was computed as the function of time (in DMD time unit, t.u., see Appendix 
A) from ten independent simulations (in different colors) of the coarse-grained molecular system. 
(b) The average number of ubiquitins bound to AgNP, <Nbound>, features a power-law 
(approximately linear) in a log-log plot. A power-law fit has an exponent of 0.21. A stretched 
exponential, ~1-exp(-ctα), better fits the data with α = 0.34.  (c) The final structure from one of 
the simulations (corresponding to the black line with the highest Nbound in panel a). The 
ubiquitins are in cartoon representation. The citrates correspond to the red spheres. The large gray 
sphere denotes the AgNP, and the blue spheres on the surface of the AgNP are the positively 
charged atoms. One of AgNP-bound ubiquitin is unfolded on the nanoparticle surface (right). In a 
coarse-grained DMD simulation with a higher stoichiometry of ubiquitin to AgNP (50:1), 
ubiquitin (black line) competed with citrate (red) to bind AgNP by displacing initially-bound 
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citrates (d). At this high stoichiometry, multi layers of ubiquitins were found to deposit onto the 
surface of the AgNP (e)., Fig. 3.2 a). Two regions, one near the C-terminal of the helix and 
the other close to residue 46 in a loop, were significantly destabilized upon binding. The 
destabilization of protein helix due to AgNP-binding is consistent with our circular 
dichroism (CD) measurement (Appendix B), which revealed that the helical content was 
reduced by 27.8% relatively for the AgNP-bound ubiquitins compared to the free 
ubiquitins (Fig. 3.5 b). Our CD experiment also revealed small increase in the β-sheet 
content. Since the Q-value is computed based on protein native structure, it cannot 
measure the gain of secondary structures beyond the native state. With the protein 
concentration locally enriched on the AgNP surface, the increase of β-sheet content could 
result from the formation of inter-protein hydrogen bonds between partially unfolded 
protein regions. The formation of inter-protein hydrogen could further lead to protein 
aggregation130, which requires further investigations in future studies. 
 
3. Conclusion 
 In summary, both our computer simulations and experiments showed that 
ubiquitin proteins could readily bind to a citrate-coated AgNP to render a multilayer 
nanoparticle-protein corona. Despite many negatively-charged residues scattered on the 
ubiquitin surface, our multiscale modeling revealed a specific binding between ubiquitins 




Figure 3.5. The structural change of ubiquitin upon AgNP binding. (a) The fraction of native 
contacts, Q-value, was computed for each residue for both the AgNP-bound (black) and unbound 
(blue) ubiquitins (top panel). The error bars were estimated from independent simulations. The 
yellow arrows indicate the residue segments forming β-strands, and the red rod denotes the 
residues forming the α-helix. The differences of Q-value were computed between AgNP-bound 
and unbound (bottom panel) cases. The two dashed lines correspond to deviations with one 
standard deviation above and below the average. The differences beyond the two lines are 
statistically significant. (b) The percentage of secondary structures in ubiquitin (dark blue) and in 
AgNP-ubiquitin (cyan) were probed by CD experiments (Apendix A). 
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of AgNP-ubiquitin corona formation uncovered an unusual stretched exponential binding 
kinetics, in agreement with a recent fluorescence kinetics measurement of nanoparticle-
human serum albumin corona formation191. At a high stoichiometry, specifically, 
ubiquitins formed a multi-layer corona surrounding the AgNP. Both our simulations and 
experiments showed that AgNP-binding moderately destabilized the α-helix while 
increased the β-sheet content of the ubiquitins. Taken together, our new multiscale 
modeling method was able to recapitulate various structural and dynamic characteristics 
of nanoparticle-protein corona observed experimentally, and offered an atomic detail and 
a mechanistic insight into nanoparticle-protein self-assembly. Since the topic of protein 
corona and, especially, the connections between nanoparticle-protein corona with the 
transformation, biocompatibility, and immune responses of nanoparticles are still poorly 
understood, we believe that our method will find broad implications and applications in 
the research areas of molecular self-assembly, physical adsorption, nanobiophysics, 
nanomedicine, and the health and safety of nanotechnology. 
 
4. Experimental and Computational Methods 
 We combined both experimental and computational approaches to characterize 
the formation of nanoparticle-ubiquitin corona formation. The details of both 






EFFECTS OF NANOPARTICLE SURFACE CHEMISTRY ON NANOPARTICLE 
BINDING AND PROTEIN STRUCTURE 
Radic, S et al. Effect of fullerenol surface chemistry on nanoparticle binding-induced protein 
misfolding. Nanoscale 2014, 6, 8340. Reproduced with permission of The Royal Chemical 
Society. 
1. Introduction 
 Since their discovery, fullerene nanoparticles have attracted much attention due to 
their small sizes (~1 nm in diameter), caged structures, and distinct physicochemical 
properties. The ultrafine structures allow these nanoparticles to cross even the most 
difficult biological barriers, e.g. blood-brain barrier,193,194 and reach different parts of the 
body, making them attractive drug and gene delivery vehicles.195,196 Given their redox 
potentials as anti-oxidants197,198 and relatively low toxicity,199 fullerenes and their 
derivatives have also been investigated as novel drugs.78,79,81,88,196 Specifically, 
functionalized fullerene derivatives have been found to inhibit the growth of sarcomas200 
and alleviate allergic responses.201 Like many other types of nanoparticles, fullerene 
derivatives can bind to a wide range of proteins upon entering a biological system. For 
instance, it was found that fullerenes can bind to HIV protease,78 influenza viruses,81 
serum albumin202,203 and fullerene specific antibodies.204 In light of the fact that 
increasing production and potential biomedical applications will eventually lead to 
human exposure to these carbon-based nanoparticles, it is essential to delineate the effect 
of fullerene-binding on the structure, dynamics and subsequent functioning of proteins, 
the building blocks of cellular life. 
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A major limitation for the use of pristine fullerene C60 has been its low solubility 
in water, and the need for special treatments like sonication, encapsulation in special 
carriers or use of co-solvents.196 Alternatively, these hydrophobic nanoparticles can be 
functionalized with polar groups to better enable their designed biological and biomedical 
applications. One of the common functionalization strategies is hydroxylation, where 
polar hydroxyl (-OH) groups are chemically attached to the surface of fullerene 
nanoparticles to render soluble fullerenols.196,205 Depending on the particular chemical 
procedures used to hydroxylate the fullerene, the number of OH groups on the 
hydroxylated fullerene (i.e., fullerenol C60(OH)n) may vary, assuming values of n=4, 6, 8, 
20, 24, and 36,206–209 for example. As one would expect, the solubility of fullerenol 
particles increases as the number of hydroxyl group is increased.210 However, the effect 
of variations in nanoparticle surface chemistry on protein-fullerenol binding, including 
both structure and dynamics of protein-nanoparticle complex on the molecular and 
atomic levels, is largely unknown. 
Various computational studies have been conducted in order to uncover the 
molecular mechanisms of the interactions between proteins and various fullerene 
derivatives. Using molecular dynamics (MD) simulations, hydroxylated fullerenols 
C60(OH)20 were bound to  tubulin211 and taq DNA polymerase212 via the formation of 
hydrogen bonds. Fullerenes were also investigated in silico as a potential potassium 
channel blocker.213 Through molecular modeling, fullerenes conjugated with small 
ligands were exploited as potential drugs to competitively bind the active sites of HIV-1 
protease78 and H5N3 influenza virus endonuclease.81 Most of these previous studies, 
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however, focused on either pristine fullerenes or highly hydroxylated fullerenols. 
Recently, molecular docking has been applied to investigate the influences of size and 
extent of hydroxylation of fullerenols on their interactions with a variety of proteins, 
including RNA reverse transcriptase, RNase A, HIV-1 protease and tubulin.214 It was 
found that the driving force of protein-fullerenol interaction was π-stacking and the 
increased number of hydroxyl groups resulted in a decreased binding affinity. However, 
since molecular docking studies assumed the protein conformation static or with only 
minor changes, variations in protein structure and dynamics upon nanoparticle binding as 
observed in many experiments211,215,216 cannot be obtained. 
Here, we applied a set of computational methods, including both docking and MD 
simulations, to systematically study the effect of fullerenol surface chemistry on its 
interaction with proteins, with the focus on changes in protein structure and dynamics. 
We used ubiquitin as the model protein since it is ubiquitously expressed in all eukaryotic 
cells217 regulating protein distribution and recycling,218 thus rendering our study both 
biologically and ecologically relevant. Specifically, we performed atomistic MD 
simulations with both explicit and implicit solvents. For the implicit solvent simulations, 
we used discrete molecular dynamics (DMD) simulations, a rapid conformational 
dynamics sampling algorithm181 for biomolecules and molecular complexes. Compared 
to all-atom MD simulations with explicit solvent, DMD simulations with implicit 
solvents are able to reach longer time scales, which allowed direct observation of protein 
folding ab initio219,220 and the observation of nanoparticle-protein corona formation.117,221 
For highly hydroxylated fullerenols, both our conventional MD and DMD simulations 
56 
 
suggested that the nanoparticles bound to the surface of ubiquitin via hydrogen bonds and 
the protein maintained its native structure. As a proof of the concept and in consideration 
of technical difficulty in accurately controlling the number of hydroxyl groups and 
solubilizing fullerenes, experiments were carried out only for highly hydroxylated 
fullerenol, C60(OH)20. We find that the binding sites derived from both docking and MD 
simulations are consistent with our fluorescence and isothermal titration calorimetry 
(ITC) measurements. As the number of hydroxyl groups decreased and the nanoparticles 
became subsequently more hydrophobic, both DMD and MD simulations revealed that 
the nanoparticles bound the protein via hydrophobic interaction and π-stacking. Only in 
DMD simulations, we were able to observe large-scale protein conformational dynamics 
that takes place on longer time scales, allowing the hydrophobic nanoparticle to partition 
into the protein core and subsequently disrupt the native protein structure. Overall, our 
results indicate that fullerenols with limited hydroxylation can induce protein misfolding, 
which could potentially trigger protein aggregation and adverse biological 
responses.222,223 
 
2. Results and Discussions 
 Due to its high solubility and commercial availability, fullerenol with ~20 
hydroxyl groups C60(OH)20  (buckyusa.com) is one of the most well-studied fullerene 
derivatives in both experiments140,211,224,225 and simulations.140,211,212,226–228 Therefore, we 
first focused on the binding of C60 and C60(OH)20 to ubiquitin using various 
computational methods, including molecular docking, MD (explicit solvent) and DMD 
57 
 
(implicit solvent) simulations. The simulation results of only C60(OH)20 were compared 
to experimental characterizations by fluorescence quenching, ITC, and circular dichroism 
(CD) spectroscopy. Experiments with pristine and low hydroxylated fullerenes were not 
carried out due to their poor solubility. 
 Fullerene C60 and fullerenol C60(OH)20 binding with ubiquitin. First, docking 
simulations were performed to identify the potential binding sites of C60 and C60(OH)20 
nanoparticles on ubiquitin (Methods). The fullerenol nanoparticles showed two preferred 
binding sites on ubiquitin (see Fig 4.1 A). In 57% of docking simulations, C60(OH)20 
bound to the protein surface region near residues 59–63, while in another 34% of 
simulations binding took place near the protein C-terminal (see Fig. Appendix B1 for a 
detailed view of the binding sites). The binding scores for these two sites are 8.2 and 8.1 
kcal/mol, respectively. On the other hand, pristine fullerene showed only one 
predominant binding site that was similar to the first binding site of fullerenol, near 
residues 60–63 (Fig 4.1 B). The nanoparticle bound to this site in 90% simulations, with a 




Figure 4.1. The predicted binding structures between ubiquitin and fullerene-based 
nanoparticles. The computational modeling approaches include molecular docking (A, B), MD 
simulations with explicit solvent (C, D), and DMD simulations with implicit solvent (E, F). The 
panels (A, C, E) correspond to the results for fullerenol C60(OH)20 binding, and panels (B, D, F) 
illustrate the binding with fullerene C60. The protein backbone is shown in cartoon and the side-




 Next, we performed both MD and DMD simulations of nanoparticle-ubiquitin 
binding (Methods). We started the simulations by placing 13 C60 or C60(OH)20 
nanoparticles randomly around the protein. High nanoparticle-protein stoichiometry 
(13:1) was set up in order to observe multiple protein-nanoparticle binding events in one 
simulation. In both DMD and MD simulations, the hydrophilic C60(OH)20 nanoparticles 
bound to the protein surface at various locations via diffusion. Once bound, the particles 
started to diffuse on the protein surface and eventually formed clusters near the preferred 
binding sites. The final structures from MD (Fig 4.1 C) and DMD (Fig 4.1 E) simulations 
are highly similar, where the protein maintained its native-like structure while the 
nanoparticles form clusters near two similar binding sites. Interestingly, the two binding 
sites observed in MD and DMD simulations agree with these obtained from docking 
simulations. The binding in the proximity of TYR59 residue is also consistent with our 
fluorescence quenching experiment. Ubiquitin possesses only one tyrosine (TYR59), 
whose fluorescence intensity was measured for four different concentrations of C60(OH)20 
at a given ubiquitin concentration. A linear static quenching of fluorescence intensity was 
observed with increasing C60(OH)20 concentration (Fig. Appendix B2). This observation 
indicates that C60(OH)20 molecules bound the protein specifically in the proximity of 
TYR59. The binding was further characterized by ITC measurement, which showed that 
an average of 1.3 fullerenol molecules bound to the protein (Fig. Appendix B3). This 
observation can be explained by the fullerenol preferential binding to two distinct sites of 
ubiquitin (near TYR59 and C-terminal). Different binding affinities of these two sites 
might result in the fullerenol:protein stoichiometry less than 2. Both the fluorescence 
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quenching and ITC experiments indicated that the binding affinity between C60(OH)20 
and ubiquitin is 10–100 μM. The ITC derived stoichiometry is consistent with the 
simulation result of two binding sites per protein. Therefore, both our simulations and 
experiments are in agreement in terms of ubiquitin-C60(OH)20 binding, highlighting the 
predictive power of computational modeling for addressing nanoparticle-protein 
interactions. 
In the fullerene-protein binding simulations, we found that the final protein 
structures from MD (Fig 4.1 E) and DMD (Fig 4.1 F) simulations were drastically 
different. In the DMD simulations, specifically, the hydrophobic fullerene nanoparticles 
eventually moved from the surface into the hydrophobic core of the protein. As a result, 
the protein was partially denatured with only a few native secondary structural elements 
remaining intact. Similar large protein conformational changes induced by binding of 
various types of hydrophobic carbon-based nanoparticles have been observed in both 
experiments172 and simulations.138 For example, serum proteins were found to undergo 
large conformational changes in the presence of multiwalled carbon nanotubes,172 while 
MD simulations showed that a singlewalled carbon nanotube was able to partition into 
the core of a WW-domain protein to disrupt its native structure.138 However, such large 
conformational changes were not observed in our accompanying MD simulations of 
fullerene-ubiquitin binding, where nanoparticles remained on the protein surface with 
similar binding sites as that for C60(OH)20 and the protein maintained its native-like 
structure. We hypothesize that the differential structures observed in the MD and DMD 
simulations of fullerene-ubiquitin binding are the result of the different time scales that 
61 
 
can be reached by implicit and explicit solvent within similar simulation times. Without 
friction due to solvent molecules, protein dynamics is known to be faster in implicit 
solvent simulations.229 The key question here is given the same time scales in DMD 
simulations why C60 was able to denature the protein while C60(OH)20 was not. Next, we 
examined protein conformational dynamics in the presence of different nanoparticles 
using DMD simulations. 
 Differential protein conformational dynamics induced by C60 and C60(OH)20. 
To avoid the complexity of nanoparticle-nanoparticle and nanoparticle cluster-protein 
interactions, we performed DMD simulations of a single nanoparticle, C60 and C60(OH)20, 
interacting with a single protein ubiquitin. We monitored the root-mean-square deviations 
(RMSD) of protein conformation with respect to its native structure, the center-of-mass 
distance between the protein and the nanoparticle (dCM), and the number of protein 
residues (NC) in contact with the nanoparticle (typical simulation trajectories exemplified 
in Fig 4. 2). A residue was considered in contact with the nanoparticle if any of its heavy 
atoms were within 5 Å of the nanoparticle heavy atoms. Upon binding C60(OH)20, the 
RMSD value of the protein fluctuated around 2–3 Å with transient, large fluctuations 
occasionally approaching 4 Å (Fig 4.2 B) as observed in DMD simulations of ubiquitin 
alone without nanoparticle (Fig. Appendix B4). The contact number between protein and 
nanoparticle remained within 15 Å while the nanoparticle stayed on the protein surface 
with dCM >15 Å (e.g., the snapshot structures along the trajectory in Fig 4.2 B).  
In the case of C60, the initial fluctuations of RMSD, contact numbers, and 
intermolecular distance dCM upon nanoparticle binding were similar to those of C60(OH)20 
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binding (Figs. 3.2 A,B). After some large conformational fluctuations with RMSD 
around 2–3 Å (3.5x105 – 5x105 DMD time unit, t.u.), the contact number NC increased to 
> 20 while the intermolecular distance dCM reduced to ~5 Å. Eventually, the RMSD of 
the protein increased above 4 Å. The snapshot structure (inserts of Fig 4.2 A) indicated 
that the protein partially unfolded as the nanoparticle partitioned into the protein.     
Taken together, since larger conformational changes often require higher energy 
changes and thus have lower probabilities for occurrence, the longer effective time scales 
in the DMD simulations allowed the observation of ubiquitin conformational dynamics 
with larger RMSD values (Fig 4.2 and Fig. Appendix B4) compared to the MD 
simulations with explicit solvent (Fig. Appendix B5). The observed C60-ubiquitin 
structures in MD simulations (Fig 4.1 D) were consistent with the initial phases of C60 
binding with ubiquitin, where nanoparticles remained on the protein surface without 
denaturing the protein (Fig 4.2). With large conformational changes populated along the 
DMD simulation trajectory, the protein partially exposed its hydrophobic core and the 
hydrophobic C60 was able to plug into the protein core to cause denaturation. On the other 
hand, the hydrophilic C60(OH)20 stayed on the protein surface as the protein folded back 
into its native state, results in transient large conformational fluctuations as observed also 
in DMD simulations of ubiquitin without any nanoparticles (Fig. Appendix B4). 
Therefore, the major reason for the differential protein dynamics upon binding to the 
nanoparticles is the difference in the nanoparticle surface chemistry — the number of 
hydroxyl groups. Next, we performed DMD simulations of protein binding with 




 Figure 4.2. The binding trajectories in DMD simulations. Differential conformational 
dynamics of ubiquitin were observed upon binding fullerene C60 (A) and fullerenol C60(OH)20 (B). 
The RMSD of ubiquitin, the number of residues in contact with the nanoparticle (NC), and the 
inter-molecular distance between the corresponding centers of mass (dCM) were monitored as the 
function of simulation time, in the unit of DMD time unit (t.u.; see Methods). The snapshot 





Figure 4.3. The equilibrium binding between ubiquitin and fullerenols with various 
numbers of hydroxyls. (A) The fullerenols C60(OH)n used in simulations, where n=0, 4, 8, 12, 
16, and 20, are shown in sticks. Based on multiple independent DMD simulations with different 
initial conditions, we computed the histogram of (B) inter-molecular distances, dCM, (C) number 
of contacting residues, NC, an (D) the RMSD of the protein. The arrows highlight the significant 
changes in the histogram plots that correlate with the changes in the number of hydroxyl groups 
 
Ubiquitin-fullerenol binding with different extent of hydroxylation. We investigated 
the interactions between ubiquitin and nanoparticles with intermediate hydroxylation, 
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including 4, 8, 12 and 16 hydroxyl groups and thus having intermediate surface 
hydrophobicity as well as various degrees of hydrogen bond donors and acceptors (Fig 
4.3 A). For each fullerenol derivative, we performed DMD simulations with a single 
nanoparticle and a single protein. To avoid potential bias of initial condition and to 
increase sampling statistics, we performed 20 independent simulations with different 
initial intermolecular positions and orientations (Methods). Based on the independent 
DMD simulations, we calculated distributions of the intermolecular distance dCM  (Fig 4.3 
B), the number of residue contacts NC (Fig 4.3 C), and the protein RMSD (Fig 4.3 D). We 
found that as the number of surface hydroxyl groups decreased the fullerenol exhibited an 
increased probability to penetrate into the protein core (with low dCM < 10 Å and large 
number of residue contacts NC > 20) and consequently denatured the protein (with RMSD 
> 4 Å). Interestingly, we found that these nanoparticles can be approximately divided into 
two categories based on their binding behaviors, i.e., the more hydrophobic C60, 
C60(OH)4, and C60(OH)8, and the more hydrophilic C60(OH)12, C60(OH)16, and C60(OH)20. 
The more hydrophobic fullerenols (C60(OH)4 and C60(OH)8) behaved like the pristine 
fullerene C60, while C60(OH)12 and C60(OH)16 were similar to C60(OH)20 (Figs. 3.3 B-D). 
Due to smaller number of surface hydroxyls, the hydrophobic fullerenols have large 
hydrophobic patches on the surface, which can be buried inside the protein and thus 
disrupt the protein native structure. As the number of hydroxyl groups increases, the 
available hydrophobic patches and their sizes decrease, which allow the nanoparticles to 
stay on the protein surface upon protein binding.  
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In order to quantify the detailed binding between fullerenol and protein residues, 
we computed the average contact frequency between each residue and the corresponding 
nanoparticle (Fig 4.4). We colored the residues in the protein structure according to their 
binding frequencies (Fig 4.4 B). Compared to the more hydrophilic fullerenols, i.e., 
C60(OH)n with n≥12, the binding of the more hydrophobic (n<12) nanoparticles with the 
protein appeared mostly non-specific, including significant probabilities to interact with 
the buried residues. As the number of hydroxyl groups increased, the binding of 
hydrophilic fullerenols with the protein became more specific. For instance, the binding 
sites of fullerenol C60(OH)20 include the region near TYR59 and C-terminal (Fig 4.4 B). 
The C-terminal binding has a weaker probability (yellow color) compared to the binding 
near TYR59 (red color), consistent with the estimated binding probabilities from docking 
simulations.  
Even though solubility increases as more hydroxyl groups are added to the 
nanoparticle surface,210 our simulation study suggests that, compared to pristine fullerene 
C60, fullerenol C60(OH)8 was still able to denature the bound proteins. Possibly due to the 
small size of the fullerenol nanoparticle, the extent of protein conformational change 
upon binding a single nanoparticle was relatively small as the increase of RMSD was 
relatively small (Figs. 3.2, 3.3). Next, we examined the effect of multiple fullerenol 





Figure 4.4. The contact frequency between fullerene and each protein residue. (A) The 
average contact frequency is computed over the independent DMD simulations, and the error bars 
correspond to the estimated standard errors. The schematics of protein secondary structures were 
shown underneath the sequence index, where arrows correspond to strands and cylinders denote 
helices. (B) In the native structure, we colored each residue according to their contact frequencies 




Protein structural changes upon fullerenol binding. We performed DMD simulations 
with a ubiquitin protein interacting with multiple fullerenols of C60(OH)n, where n=0, 8, 
20. Multiple independent simulations with different initial conditions were performed to 
enhance the sampling statistics. Averaged over the independent simulations, we 
computed the protein RMSD as the function of simulation time (Fig 4.5 A). Fullerene C60 
had the greatest effect in terms of protein denaturation, with the highest RMSD of ~ 8 Å 
at the end of the DMD simulations. The protein core was loaded with multiple 
nanoparticles (Figs. 3.1, 3.5). As expected, fullerenol C60(OH)8 was also able to denature 
the protein, with RMSD > 4.5 Å; however, these nanoparticles could not fully penetrate 
the protein and were partially buried into the protein (Fig 4.5 A) to compromise the 
structure of the protein. Interestingly, the C60(OH)20-bound ubiquitin exhibited a smaller 
RMSD compared to the reference simulations where the nanoparticle was absent. The 
decreased RMSD in the presence of C60(OH)20 is likely due to the fact that a high number 
of surface hydroxyl groups on the nanoparticle surface was able to establish multiple 
hydrogen bonds with the protein side chains, thereby reducing their thermal fluctuations. 
To estimate the changes in protein secondary structures upon nanoparticle binding, we 
also calculated the average secondary structure contents of the ubiquitin using a method 
proposed by Srinivasan and Rose230 (Fig 4.5 B).  The average was taken over multiple 
independent simulations. Compared to the reference simulations of ubiquitin alone, 
binding of fullerene and various fullerenols consistently reduced the content of α-helixes 




Figure 4.5. The tertiary and secondary structures of ubiquitin induced by multiple 
nanoparticle binding. (A) We monitored the average RMSD of ubiquitin as the function of 
DMD simulation time. Typical complex structures obtained from simulations were shown as 
inserts. The simulations with protein only were used as the control for comparison. (B) The 
secondary structure contents were computed from DMD simulations of ubiquitin upon binding 
fullerenols with various numbers of hydroxyls. (C) The experimentally measured protein 
secondary structure elements. 
The changes in β strands are relatively small without obvious trends. Among the modeled 
nanoparticles, fullerene C60 had the strongest effects in terms of affecting protein 
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secondary structures. Experimentally, due to solubility and availability issues, we only 
performed CD measurements of ubiquitin alone and ubiquitin incubated with C60(OH)20 
(Methods; Fig. Appendix B6 and Fig 4.5 C). The experimentally measured changes in 
secondary structure contents were qualitatively consistent with the predicted changes 
derived from DMD simulations. Although there are differences in the absolute values of 
secondary structure contents between experiments and simulations, the changes upon 
fullerenol bonding are in accord with each other, including slight decreases in alpha 
helices, and increases in β sheets and random coil content (Figs. 3.5 B, C). 
 
3. Conclusion 
 We studied the binding of ubiquitin with fullerene and its fullerenol derivatives, 
C60(OH)n with various number of hydroxyls, n. We find that while hydrophilic fullerenol 
binding primarily on the protein surface, the hydrophobic fullerenes enter into the core of 
the protein and denature it. In the case of C60(OH)20 for which experiments were 
possible,, agreement between experimental measures (including ITC, fluorescence 
quenching, and CD) and various computational methods (docking, MD with explicit 
solvent, and DMD with implicit solvent) underscore the predictive power of 
computational modeling for nanoparticle-protein interaction. Most importantly, the 
ability of DMD simulations to sample longer time scales than traditional MD simulations 
with explicit solvent allowed the observation of protein denaturation with hydrophobic 
fullerene C60. The denaturation of proteins by hydrophobic carbon-based nanoparticles 
has already been observed experimentally.172,231–233 Considering the technical difficulty in 
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controlling the number of hydroxyls and low solubility of fullerene nanoparticles, we are 
unable to experimentally verify the misfolding induced by fullerene nanoparticles. Our 
study has shown that DMD simulations can be used as an efficient tool for unraveling the 
complex phenomena at the nano-bio interface, such as delineating the structure and 
dynamics of nanoparticle-protein corona158 in order to better understand nanotoxicity and 
thereby enable improved applications of nanomedicine. 
 The surface chemistry of nanoparticles is an important determinant of their 
interactions with proteins in addition to the nanoparticle size and shape.158 In this work, 
we studied the effect of different extent of hydroxylation, where the surface hydroxyl 
groups can serve as both donor and acceptor for hydrogen bonding. Our results suggested 
that different extent of hydroxylation had significant effects on C60(OH)n-protein 
interactions. Specifically, fullerenols with n≤8 were able to denature the protein since 
their relatively small number of hydroxyls allowed more hydrophobic patches on the 
nanoparticle surface (Fig 4.3 A) and significant interactions with the protein hydrophobic 
core to disturb its tertiary structure. Hydrophilic nanoparticles, in contrast, remained 
bound on the protein surface without inducing major structural changes. In fact, 
hydrophilic particles, especially C60(OH)20, could form multiple hydrogen bonds with 
protein surface residues to reduce structural fluctuations (Fig 4.5 A). Taken together, our 
study revealed a distinctive role of surface hydroxylation in term of nanoparicle-binding 
induced protein misfolding. With the advancement of computational modeling of the 
nano-bio interface and improvement of the predictive power, it might be possible to 
accurately adjust the nanoparticle surface chemistry in order to reduce the potential 
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adverse effects such as nanoparticle-binding induced protein misfolding and 
concomitantly increase the nanoparticle biocompatibility. 
 
4. Methods 
Docking. C60 and C60(OH)20 were docked on to human erythrocyte ubiquitin structure 
obtained from the protein data bank (PDB ID: 1UBQ234). Three of 76 residues of this 
structure are different from the A. thaliana ubiquitin, which was used in experiments. 
Docking simulations were performed using AutoDock 4.2 docking software235 with its 
default force field. Fifty docking simulations, each with 10 trials, were carried out 
keeping both protein and nanoparticles rigid. A Lamarckian genetic algorithm235 with 
2.5x107 evaluations was used. The resulting docked poses were clustered based on their 
mutual root-mean-square deviation values, using a cutoff of 0.8 nm. Here, the larger than 
usual cutoff value of 0.2 nm was used because the nanoparticle was able to bind the same 
site by rotating around its center of mass. 
Molecular Dynamics (MD). The MD simulations were carried out using GROMACS 
simulation package version 4.5.4236 with OPLSAA force field237,238 for protein and a 
compatible parameter set for nanoparticles as described elsewhere212. The protein-
nanoparticle complex was placed in a simulation box whose edges were at least 0.9 nm 
away from the solute. The box was then filled with TIP4P239 water molecules. NA+ and 
CL- ions were added so that the simulation box had an ion concentration of 100 mM. The 
system was energy minimized between each of these steps using steepest descent 
algorithm. First, the simulation system was equilibrated with a 50 ps long NVT 
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simulation, which was followed by a 100 ps long NPT simulation. During these 
equilibrium runs, the temperature and pressure of the system were coupled using the 
Bussi-Donadio-Parrinello velocity rescale algorithm240 (298 K, τT = 1 ps) and Berendsen 
weak coupling algorithm241 (1 bar, τP = 4 ps, only for NPT simulation), respectively. For 
production runs, the Bussi-Donadio-Parrinello velocity rescaling algorithm and Parinello-
Rahman algorithm242 were used for temperature (298 K, τT = 1 ps) and pressure coupling 
(1 bar, τP = 4 ps), respectively. Six independent copies of each simulation were carried 
out, each lasting 100 ns. The simulation time step was set at 2 fs with all bonds 
constrained using the LINCS algorithm.243 The electrostatic interactions were treated 
with smooth PME method,244,245 with a cut-off of 0.9 nm. For Lennard-Jones interactions 
a cut-off of 1.4 nm was used without any switch or shift functions. 
Discrete Molecular Dynamics (DMD) Simulations. 
In our DMD simulations, fullerene derivatives with 0, 4, 8, 12, 16 hydroxyl 
groups were prepared by randomly removing –OH groups from fullerenol, whose 
structure was taken from a previous C60(OH)20 model.85,86 The system was modeled and 
visualized using PyMOL.246 Single nanoparticle simulations were carried out at room 
temperature 300 K. Dimensions of the simulation box were set at 75 Å in all three 
dimensions and periodic boundary conditions were imposed. Prior to simulation, 
ubiquitin and the nanoparticle were positioned away from each other. Initially, system 
was equilibrated for 5 ns and followed by 50 ns production simulations. Twenty 
independent simulations with difference initial conditions, including relative inter-
molecular distance and orientation as well as velocities, were performed in order to 
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reduce the sampling bias of initial conditions and to increase sampling statistics. During 
the simulation we monitored protein RMSD. For comparison, multiple independent 
simulations of ubiquitin alone without nanoparticles were performed without any 
nanoparticle.  
For the study of ubiquitin binding with multiple nanoparticles, 13 nanoparticles 
and one protein were initially positioned away from each other in a cubic simulation box 
of 100 Å. We chose to simulate three representative cases: insoluble fullerene C60, 
partially hydrophobic C60(OH)8 and hydrophilic fullerenol C60(OH)20. For each case, 10 
independent DMD simulations were performed and each simulation followed the same 
protocol as the single nanoparticle binding simulations.  
Fullerenol Preparation. A stock of fullerenols (BuckyUSA) 1 mg/ml dispersed in 
Milli-Q was firstly sonicated and then the new 10x diluted filtered stock was made for the 
measurements.  Filtration was done with Anotop filters (0.1 μm, Whatman).  
Fluorescence measurements. Further study of the ubiquitin fullerenol interaction 
was done by fluorescence quenching study of ubiquitin (A. thaliana) tyrosine (Y) residue 
(MQIFVKTLTGKTITLEVESSDTIDNVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTL
ADYN IQKESTLHLV LRLRGG) by adding fullerenols into solution. The experiment 
was performed on a Varian Eclipse fluorometer. Concentrations of added fullerenol in 
solution were 9.43 mM, 15.7 mM, 23.6 mM, and 47.2 mM, while the ubiquitin 
concentration was held constant at 10 mM. The mixtures were incubated for 2 h before 
the measurement. The excitation wavelength was 220 nm and the observed emission was 
303 nm, which is the emission wavelength characteristic for tyrosine residue. We fitted 
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data with the Stern-Volmer equation:247 
  (4.1)                      
where Io is emission intensity of the ubiquitin without added fullerenol, and I is the 
emission intensity of ubiquitin when fullerenol with a concentration of CFUOH is added to 
the protein. 
To account for apparent quenching, we corrected our intensities considering our 
cell geometric and absorption characteristics.  The correction is described by Parker 
equation:248 
    (4.2) 
Where Icorrected and Iobserved are the corrected and observed intensities, Aex and Aem are 
absorbance per centimeter at the excitation and emission wavelengths, and parameters s, 
g and d depend on the geometry of the measurement. 
 Isothermal titration calorimetry (ITC). The thermal dynamics of the binding 
between fullerenol and ubiquitin was investigated using an isothermal titration 
calorimeter (ITC, TAM III, TA Instruments). 1.88 mM of fullerenol solution (in Milli-Q 
water) was placed in the glass syringe, and then was titrated into the ampoule containing 
0.1 mM ubiquitin solution (in Milli-Q water) at the rate of 9.975 μL per injection. The 
time interval between two consecutive injections was set to 15 min, and total 25 
injections were performed. The raw data was pre-processed using TAM Assistant, and 
imported into NanoAnalyze, then fitted using the built-in Independent Model to render 
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the thermal dynamics of the binding, which yields n=3.083, Ka=6.324x104 M-1, 








DIFFERENTIAL BINDING OF MULTIPLE AMPHIPHILES TO NANOSHEETS 
Radic, S et al. Competitive Binding of Natural Amphiphiles with Graphene Derivatives. 
Sci. Rep. 2013, 3, 2273. Reproduced with permission of Nature Publishing Group. 
1. Introduction 
 Due to their unique physical properties37,249,250, graphene and graphene derivatives 
have emerged as ideal materials for constructing novel nano- and quantum devices. The 
potential applications of graphene derivatives range from electronic circuits and energy 
storage to biomedical nanodevices for imaging, sensing, and diagnosis45,251–254. The 
increasing application and foreseeable mass-production of graphene derivatives255,256, 
however, will likely lead to their environmental discharge, while advances in graphene-
based nanomedicine will induce biological exposure to such engineered nanostructures. 
Consequently, it has become increasingly crucial to delineate the transformation, 
evolution, transport, and biocompatibility of graphene derivatives in the aqueous phase, 
ranging from biological to environmental systems257.  
 Once discharged into the environment or introduced to biological systems, 
graphene derivatives may interact with natural organic matter, biomolecules, and other 
ionic and molecular complexes through self assembly and chemical reactions. Most of 
these natural and bio-materials are amphiphilic in nature, and are usually comprised of 
carbohydrates, peptides, and fatty acids. Since natural amphiphiles may bind with 
graphene derivatives to render a biocorona161,258, it is conceivable that the fate of 
graphene derivatives in biological systems and the environment is determined by the 
entity of the biocorona rather than the nanomaterial substrates alone. Possessing vastly 
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different molecular morphology and physicochemical properties, natural amphiphiles are 
expected to feature distinct binding affinities for graphene derivatives to ascribe the latter 
new physical chemical and/or biological identities. Furthermore, differences in the 
concentration and affinity of natural amphiphiles may lead to their competitive binding 
for graphene derivatives, similar to the Vroman effect that is exhibited by serum proteins 
adsorbed onto solid surfaces259.  
 The binding of small ligands and peptides to graphene derivatives has been a 
subject of a few recent studies. For example, Dai et al. showed that simple physisorption 
through π-stacking could be exploited to load doxorubicin -- a commonly used cancer 
drug -- onto graphene oxide260. It was demonstrated that uniformly dispersed graphene 
oxide261,262 in a chitosan-ferrocene matrix became positively charged, thereby boosting its 
capacity to stabilize biomolecules such as glucose oxidase and consequently facilitate the 
fabrication of a glucose biosensor253. Katoch et al. showed that a dodecamer peptide 
could bind to graphene by orienting its aromatic residues, such as tryptophan and 
histidine, parallel to the nanosheet; by comparing the binding affinities of mutant 
peptides with tryptophans substituted by alanines the researchers identified an essential 
role of tryptophan in attributing to the strong binding of the peptide and the graphene48. 
The stability of peptides adsorbed onto a graphene nanosheet was studied through coarse-
grained simulations, which underpinned the importance of π-stacking, van der Waals, and 
hydrophobic interactions in the binding49,50. Density functional theory calculations were 
employed to study how biomolecular adsorption could affect the density of states of 
graphene nanosheets263. These studies, however, mostly focused on the binding of 
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graphene derivatives with single-molecular or single-component amphiphiles. A 
systematic study of the binding of graphene derivatives with a collection of representative 
natural amphiphiles is essential for elucidating the transformation and dynamics of 
graphene derivatives in complex biological and environmental media.  
 Herein we combined computational modeling and experimental characterizations 
to examine the binding of graphene and graphene oxide with natural amphiphiles. 
Specifically for simulations, we adopted cellulose dimers, tri-alanine peptides, and 
palmitic acids as model amphiphiles (Fig. 5.1) to represent the sugar, peptide, and fatty 
acid moieties present in algal exudates used in our experiments, respectively. In addition 
to being prevalent in aquatic environments, these molecular species are also ubiquitous 
across the biosphere of living organisms. We performed discrete molecular dynamics 
(DMD) simulations, a rapid dynamic sampling algorithm264 to characterize the binding 
between the graphene derivatives and the natural amphiphiles. The molecular systems 
were modeled using the united atom representation, in which polar hydrogen and heavy 
atoms were explicitly modeled. The simulations were performed with implicit solvent, 
and the inter-atomic interactions were modeled by a physical force field adapted from 
Medusa182, which include van der Waals, solvation183, electrostatic, and hydrogen 
bond180,265. In our simulations, graphene nanosheet was presented as a two-dimensional 
honeycomb, where its aromatic carbon atoms featured van der Waals and hydrophobic 
interactions. In contrast, graphene oxide was modeled by introducing defects, 
epoxidations, hydroxylations, and carboxylations to its graphene backbone (Fig. 5.1). 
These modifications rendered the graphene oxide surface more hydrophilic in 
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physicochemistry and rugged in morphology than graphene. 
 
2. Results 
 Differential binding of nanosheets with single amphiphiles – temperature 
varying DMD simulations. We first characterized the dynamics of single-molecular 
binding between the nanosheets of graphene derivatives and the amphiphiles. We 
performed DMD simulations at different temperatures and monitored the binding along 
the simulation trajectories. For example, in the case of graphene oxide and cellulose266 
binding, we observed three different regimes (Fig. 5.2). At low temperatures (Fig. 5.2 a), 
the molecular system had low potential energies and the cellulose stayed bound to the 
nanosheet with a high number of atomic contacts (Nc) occurring between the two species. 
At high temperatures (Fig. 5.2 c), the cellulose molecule dissociated from the nanosheet 
with higher potential energies and a low Nc value. The two species only occasionally 










                                   Graphene                                                         Graphene Oxide  
Natural Amphiphiles 
     Cellulose  Dimer (C6H10O5)2        Peptide:  Tri-Alanine (C3H7NO2)3                 Palmitic Acid: C16H32O2    
Figure 5.1. Simulation scheme of the nanostructures of graphene and graphene oxide 
nanosheets (top row) and the natural amphiphiles of a cellulose dimer, a tri-alanine peptide, and 
a palmitic acid (bottom row). Color schemes: brown - carbon, red - oxygen, blue - hydrogen, 
green - nitrogen.   
 
Between these two extreme regimes, there existed a mid-point temperature, Tm, where the 
cellulose had approximately an equal probability of being bound and unbound to 
graphene oxide (Fig. 5.2 b). Interestingly, in the unbound state, the systems featured an 
intermediate energy state, which belonged to the excitation of a high-energy normal mode 
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due to harmonic constraint applied to confine the nanosheet (Fig. Appendix C1). 
 Therefore, the inter-molecular contact, Nc, rather than the potential energy, was a more 
appropriate parameter to monitor the binding. At Tm, the potential energies and inter-
molecular Nc values displayed large and anti-correlated fluctuations, clearly resulting 
from the interplay of enthalpy and entropy. Here the contributions of entropy include 
freedoms in both translation and configuration. The values of Tm were used to quantify 
the binding affinities between the different amphiphiles and the nanosheets. 
 Accurate estimation of Tm requires sufficient sampling of the conformational 
space. We therefore applied replica exchange DMD simulations265 (Methods) to enhance 
the sampling, where multiple simulations were running in parallel at different 
temperatures and the replica temperatures were subject to exchange periodically 
according to the Metropolis criteria267. A system in a kinetically trapped state has a 
chance to escape the local minimum by running at a higher temperature, thus enhancing 
the sampling. Based on the replica exchange simulations, we computed the 
thermodynamic parameters using the weighted histogram method (Methods)268. 
 For both graphene and graphene oxide, we performed independent replica 
exchange DMD simulations of their binding to cellulose, tri-alanine, and palmitic acid. 




Figure 5.2. Binding simulation trajectories at different temperatures. Both potential 
energy (E, blue, left vertical axis) and number of atomic contacts (Nc, orange, right vertical axis) 
are shown for DMD simulations of cellulose-graphene oxide binding. Simulations at three 
different temperatures are shown: T*=0.312 (a), 0.678 (b), and 1.146 (c), where the temperature 
unit is kcal/mol·kB 
For comparison between different molecular systems, we normalized the average Nc by 
its maximum value at low temperature to obtain the Q-value, which quantified the 
fraction of inter-molecular contacts. The amphiphiles showed a lower Tm when bound to 
graphene oxide than graphene, indicating a weaker binding associated with graphene 
oxide due to its various surface modifications that compromised inter-molecular 
hydrophobic interaction while encouraged electrostatic repulsion.  
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 Interestingly, for both graphene and graphene oxide, palmitic acid displayed the 
strongest binding while tri-alanine showed the weakest (Fig. 5.3). The strong binding of 
palmitic acid to the nanosheets correlated with its longer molecular chain that consisted 
of a higher number of hydrocarbons and hence a greater degree of chain flexibility. The 
conformational flexibility of palmitic acid allowed its long hydrophobic tail to pack 
tightly against the nanosheet, taking advantage of contributions from van der Waals and 
hydrophobic interactions. Both the cellulose and the peptide were more rigid and 
hydrophilic compared to the palmitic acid tail. In addition, the higher melting temperature 
for cellulose on graphene, compared to that for peptide, can be attributed to stacking. In 
contrast to the ring-like structure of the cellulose, the peptide backbone of tri-alanine was 
unable to form many contacts with the nanosheet. This is in agreement with the molecular 
dynamics study by Katoch et al., in which a lower binding affinity was observed when 
tryptophan residues were replaced by alanine. In the case of graphene oxide, the melting 
curves for cellulose and peptide were closer to each other (Fig. 5.3), suggesting that 
stacking was compromised by the functional groups of the nanosheet to shield its 
aromatic structure.  
  
 Differential binding of nanosheets with algal exudates – experiments. To 
complement the simulations, algal exudates were acquired from freshly cultured 
Chlorella sp. following a protocol developed in our lab269. The algal exudates were used 
to mimic the natural amphiphiles of cellulose, peptides, and fatty acids in the simulations. 
Graphene was synthesized using previously described chemical vapor deposition 
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method270 while graphene oxide was produced using the modified Hummer’s method271. 
Graphene-based materials exhibited strong Raman spectra due to the double resonance 
phenomenon272. Importantly, the overtone of disorder band (referred to as the 2D-band) 
exhibited two peaks at ~2690 cm-1 and ~2725 cm-1 (see Fig. 5.4 a).  
 
Figure 5.3. Differential binding affinities of natural amphiphiles with graphene 
derivatives. The average value of normalized fraction of contacts, <Q>, was computed as the 
function of temperatures (T*) using the weighted histogram analysis method with replica 
exchange DMD simulations (Methods). The temperature dependence of <Q> values illustrates 
the melting. For each of the three amphiphile species, the melting curves of both graphene oxide 
(“GRO”, dashed) and graphene (“GRA”, solid) are shown.  
 
This band is highly sensitive to charge transfer from substrates, dopants or any 
adsorbents. We observed that the 2D-band in graphene upshifted upon exposure to the 
algal exudates, suggesting a possible charge transfer from graphene to algal exudates. 
However, no such charge transfer was observed in the case of graphene oxide, implying a 
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weaker interaction occurring between the graphene oxide and algal exudates (Fig. 
Appendix C2), in agreement with our simulations (Fig. 5.3). Furthermore, our Fourier 
transform infrared (FTIR) spectra (Fig. 5.4 b) showed that the exudate peaks were present 
and absent in the graphene and graphene oxide incubated with algal exudates and after 
washing with de-ionized water, consistent with both the Raman spectra and the 
simulations.  
 To further examine the binding kinetics of graphene and graphene oxide with 
algal exudates, we incubated the nanosheets with exudates in water and observed their 
precipitation at different temperatures (Methods). The absorbance peak of the algal 
exudates at 205 nm was monitored over time for both graphene and graphene oxide (Figs. 
5.5 a, b). The normalized absorbance value corresponded to the total fraction of exudates 
and graphene (graphene oxide) still present in solution at a given time. This process was 
performed with fresh suspensions at both 30ºC and 35ºC.  We also performed a control 
experiment of graphene and graphene oxide in the absence of algal exudates at both 
temperatures, and did not identify significant temperature dependence of the control 






Figure 4.4. Raman (a) and FTIR (b) spectra of algal exudate-graphene/graphene 
oxide system. 1×: stock, 1/10×: ten-time diluted. 
 
 For both graphene and graphene oxide, algal exudates slowed the rate of 
precipitation at both temperatures. This general behavior is indicative of exudates binding 
with graphene and graphene oxide to render both types of nanosheets more water-soluble. 
The binding with algal exudates should also discourage π-stacking of the nanosheets, 
further slowing their rate of precipitation. The temperature-dependent behavior of 
graphene and graphene oxide with algal exudates displayed qualitatively the same trends 
– the overall difference in precipitation rate is due to the stark difference in 
hydrophobicity between graphene and graphene oxide. During the initial precipitation at 
30ºC, both graphene and graphene oxide with exudates followed the control precipitation 














exudate-nanosheet interactions to favor precipitation. The suspensions at 35ºC showed 
less pronounced precipitations, reaching a complete suspension after 50 min incubation 
with the graphene oxide. At 240-min incubation with the graphene, while the suspension 
reached 60% of normalized absorbance at 30ºC, it registered 86% of normalized 
absorbance at 35ºC in the same time period. This behavior clearly confirmed that 
significant binding occurred between algal exudates and both graphene and graphene 







Figure 5.2. UV-Vis absorbance spectra of algal exudates mixed with graphene (a) 
and graphene oxide (b) measured at 30°C (blue) and 35°C (maroon). Control kinetics 
performed in the absence of exudates at 30ºC (with no significant difference seen at 35ºC) at 
concentrations equal to test samples. 
  
Differential binding of nanosheets with multiple amphiphile species – DMD 
simulation.  To model the binding of graphene derivatives with a collection of natural 
amphiphiles in biological and environmental media, we performed a constant-
temperature DMD simulation of a graphene oxide nanosheet mixed with the three 







































peptide to palmitic acid as found in algal exudates,273 7:3:1, and accordingly we included 
14 cellulose, 6 peptide, and 2 palmitic acid molecules. The amphiphilic molecules were 
initially positioned away from the nanosheet (Fig. 5.6 a). We chose a simulation 
temperature T ≈ Tm of tri-alanine binding. This temperature allowed rapid equilibration 
while all molecules were able to bind to the graphene oxide nanosheet. 
 We then monitored the number density of molecules bound to the nanosheet along 
the simulation trajectory (Fig. 5.6 b). Due to their high concentrations, peptides and 
celluloses rapidly covered the nanosheet to form a nanosheet-amphiphile biocorona (0-8 
ns; Figs. 4.6 a, b), which hindered the binding of palmitic acids. However, due to their 
relatively weak binding affinity, the peptides and celluloses on the nanosheet underwent 
rapid exchange with the molecules in solution to assume a “soft” biocorona101. Despite 
having the lowest concentration in the simulation, palmitic acids occasionally interacted 
with the dynamic biocorona under diffusion. Once the nanosheet was available, a 
palmitic acid bound to its surface and remained bound during the course of the simulation 
(e.g., > 25 ns; Fig. 5.6 b). As a result, the biocorona became “hardened” as evidenced by 
the smaller fluctuations of the number of nanosheet-bound molecules after both palmitic 
acids were attached to the surface (t > 35 ns; Fig. 5.6 b). In the case of higher 
stoichiometric ratios of amphiphiles to the nanosheet, we expect a complete coverage of 
the nanosheet by strong binders like the palmitic acids to render a “hard” biocorona. Our 
results illustrate the general applicability of the Vroman effect for describing the binding 





 We systematically studied the interactions of graphene derivatives with natural 
amphiphiles to elucidate the general fate of graphene nanostructures in biological and 
environmental milieu. Our computational studies showed that both graphene and 
graphene oxide could bind to the amphiphiles, although graphene oxide displayed a 
weaker binding capacity owing to its surface charge and surface functionalizations. Using 
algal exudates as a model system, our experimental characterizations confirmed the 
differential binding of graphene and graphene oxide for natural amphiphiles. 
Furthermore, our simulations revealed that natural amphiphiles of cellulose, peptide and 
palmitic acid -- owing to their differences in hydrocarbon content, conformational 
flexibility, and molecular geometry -- displayed distinct binding affinities for the 
graphene derivatives. Specifically, we were able to directly observe in our simulations, 
for the first time, a Vroman-like binding during which amphiphiles of different 
abundance and binding affinity rapidly competed for the graphene nanosheet surface; 
here amphiphiles of high abundance but low binding affinity readily covered the surface 
of the nanosheet to initiate a “soft” biocorona, while amphiphiles of low abundance but 
high affinity eventually took over to render a “hard” biocorona. This study offers a 
mechanistic basis for our understanding of the physicochemical properties and the fate 














Figure 5.6. Vroman-like competitive binding of amphiphile mixture with graphene 
oxide. (a) The DMD simulation snapshots of the binding between graphene oxide and 
amphiphile mixture: t=0 ns, 8 ns, and 50 ns. (b) The number density of molecules, n, bound to the 
nanosheet is shown along the simulation trajectory. 
4. Methods 
 Construction of the model systems.  The graphene nanosheet was prepared 
using the VMD274 carbon nanostructure builder plugin 
























set as 25 x 25 Å2. The structure of graphene oxide was obtained by chemically editing the 
graphene nanosheet using Avogadro, a cross-platform molecule editor 
(avogadro.openmolecules.net)275. To mimic the experimentally-observed structural 
defects in graphene oxide276–278, we included random vacancies in the graphene oxide 
matrix. We then introduced epoxide, hydroxyl, and carboxyl groups to the lattice in a 
stochastic manner while maintaining the valences of the composing carbon atoms. After 
the introduction of defects and chemical modifications, we performed energy 
minimization using the MMFF94s force field279. Because of the introduction of sp3 
carbons on the planner carbon latter, the graphene oxide nanosheet became non-planner 
after the energy minimization (Fig. 5.1).  
 The molecular structures of cellulose dimer, tri-alanine and palmitic acid were 
generated and minimized using open babel (openbabel.org)280. We adapted the 
MedusaScore force field281, an extended Medusa force field182 for small-molecule 
ligands, to model the inter-atomic interactions of biomolecules beyond proteins282. 
 Simulation setup. The simulation was setup in a cubic box with each dimension 
of 100 Å. In our simulations, we applied harmonic constraints to the edge carbon atoms 
of graphene and graphene oxide with a weak spring constant k = 0.1 kcal/mol·Å2. The 
rest of nanosheet atoms were free to move. For each of the molecular system, we first 
performed equilibration simulations of 5 ns, and then production simulations of at least 
50 ns.  
In DMD simulations, the temperature unit is kcal/mol·kB. Here, kB is the Boltzmann 
constant. For the replica exchange simulations, we used 14 replicas with different 
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temperatures to sample the conformational space. Ranges of temperatures used in replica 
exchange were from 0.65 to 1.55 for graphene-cellulose, 0.65 to 1.4 for graphene-
peptide, 0.65 to 1.65 for graphene-palmitic acid, and from 0.35 to 1.2 for graphene oxide-
cellulose, 0.35 to 1.0 for graphene oxide-peptide and 0.5 to 1.0 for graphene oxide-
palmitic acid. The temperatures were adjusted to ensure sufficient exchange between 
replicas with neighboring temperatures and that the exchange rates were approximately 
equal.  
 To study competitive binding of the amphiphile mixtures, we placed a graphene 
oxide nanosheet together with 14 cellulose, 6 peptide and 2 palmitic acid molecules in a 
cubic box with the linear dimension of 110 Å. We followed previous report of algae 
exudate composition273 to set up the molecular system. We performed the constant-
temperature DMD simulation at T = 0.67 kcal/mol·Å2 for 50 ns. 
 Inter-molecular contacts. We monitored inter-molecule interactions by 
measuring the number of atomic contacts between two molecules, Nc. Two atoms were 
counted as in contact if the inter-atomic distance was smaller than 6.5 Å. The fraction of 
inter-molecular contacts, Q, corresponded to Nc normalized by the maximum number of 
atomic contacts when two molecules were bound at low temperature.  
 Normal modes of the nanosheet. In our simulations, we constrained the 
nanosheets with harmonic constraints in order to direct monitor amphiphile binding 
without re-centering the molecular system around the graphene sheet. As a result, the 
constrained nanosheet can undergo collective motions, i.e. normal modes, which feature 
different frequencies and corresponding energies. At low temperatures, only the low-
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energy modes that the atoms moved along approximately the same direction were 
observed. As the temperature increased, higher-energy normal modes could be excited 
(Fig. Appendix C1). 
 Weighted histogram analysis method (WHAM). The WHAM method utilizes 
multiple simulation trajectories with overlapping sampling along the reaction coordinates 
to self-consistently compute the density of states ρ(E) by combining histograms from 
different simulation trajectories283. Given the density of states, the partition function can 
be computed: Z = ρ(E)exp(−E /kBT)dE∫ . To compute any physical parameter as a 
function of temperature, we calculated the conditional probability P(A | E)  of observing a 
structure with the parameter of A at given energy E, evaluated from all simulation 
trajectories. The average RMSD as a function of temperature can be computed as 
A(T) =1/Z A⋅ P(A | E)ρ(E)exp(−E /kBT∫ )dEdA. 
 Syntheses of graphene derivatives.  Few-layer graphene samples were prepared 
using chemical vapor deposition technique. Briefly, 25 μm Ni foils were placed away 
from the center of tube furnace (diameter: 24 mm), which was maintained at 900oC under 
a flow of Ar (230 sccm) and H2 (120 sccm). After 60 min, Ni foils were moved to the 
center and graphene was synthesized by decomposing methane (10 sccm) for 10 min at a 
reduced temperature (850oC). Subsequently, methane flow was shut off and the samples 
were moved away from the center. The furnace temperature was ramped down to 400oC 
at 5oC/min and was maintained at 400oC for 90 min. The H2 flow was shut off 
immediately upon reaching 400oC, and the samples were cooled to room temperature 
under Ar flow.  
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 For solvent exfoliation of graphene, bulk graphite (~1g) was dispersed in 100 mL 
of N-methyl-2-pyrrolidinone (NMP) and sonicated using 1/8” tip sonicator (Branson 250) 
at 100 W for 2 h. The resulting dispersion was filtered through a 0.45 μm nylon filter and 
re-suspended in 100 mL of fresh NMP. Subsequently, the solution was bath sonicated for 
6 h and centrifuged at 500 rpm for 45 min. The supernatant was vacuum filtered using a 
0.45 μm nylon filter. Finally, the filtered powder was washed several times using 
deionized water to remove residual NMP. We used modified Hummer’s method to 
prepare graphene oxide.  
 Briefly, exfoliated graphene (2 g) was dispersed in concentrated H2SO4 (46 mL). 
KMnO4 (6 g) was added gradually with stirring in an ice bath. The mixture was then 
stirred at 35°C for 2 h, and deionized water (100 mL) was added. In 1 h, the reaction was 
terminated by the addition of a large amount of deionized water (300 mL) and 30% H2O2 
solution (5 mL), causing violent effervescence and an increase in temperature to 100oC, 
after which the color of the suspension changed to bright yellow. The suspension was 
washed with 1:10 HCl solution (500 mL) in order to remove metal ions by filter paper 
and funnel. The paste collected from the filter paper was dried at 60°C, until it became 
agglomerated. The agglomeration was washed several times with deionized water and 
air-dried to obtain graphene oxide samples.  
 Micro-Raman and FTIR measurement. Micro-Raman spectra were collected 
using a Dilor XY triple grating spectrometer equipped with TE-cooled CCD coupled to 
an Ar+ laser excitation at 514.5 nm. The Raman spectrum of graphene oxide exhibited a 
weaker 2D-band compared to graphene. Nonetheless, we observed that the 2D-band for 
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graphene oxide samples did not upshift (unlike graphene) upon incubation with algal 
exudates (see Appendic C Fig. C2). For FTIR measurements, the samples were incubated 
with algal exudates for 12 h. Subsequently, the samples were washed using de-ionized 
water to remove any unadsorbed exudates. For graphene oxide, the samples were 
centrifuged at 3,000 rpm for 2 h and the obtained pellets were washed in deionized water. 
Finally, the sample was air-dried overnight for performing FTIR studies. The dried 
samples were encased in a KBr matrix and their FTIR spectra were measured using a 
Bruker IFS v66 spectrometer. 
 UV-Vis measurement. For UV-Vis kinetics measurements, graphene was 
suspended in water from dry state and both graphene and graphene oxide (both 10 
µg/mL) were bath sonicated for 5 min. Algal exudates, prepared as described 
previously269, were then added and the resulting suspensions were immediately placed in 
a temperature-controlled UV-Vis spectrophotometer (Cary 300-Bio, Varian Instruments). 












PROTEIN AGGREGATION DEPENDANCE ON NANOPARTICLE-PROTEIN 
INTERACTION STRENGTH AND RELATIVE CONCENTRATION 
In preparation. 
1. Introduction 
  The interactions between proteins and NPs can also change protein structures and 
affect their corresponding functions102,284, leading to possible toxic effects116,118,285–287. 
Therefore, it is important to understand corona formation and its impact on absorbed 
proteins in order to enable the vast applications of nanomedicine. 
Because of a high concentration of proteins in the NP corona, a polymeric NP has 
been found to promote amyloid aggregation of beta-2 microglobulin, an amyloidogenic 
protein in serum130. Given the capability of NPs to cross the blood-brain-barrier195,288–291, 
many efforts has also been devoted to study the effect of NPs on protein aggregations in 
neurodegenerative diseases, such as of amyloid-beta peptide (Aβ) in Alzheimer’s disease 
(AD) 128–134,292–294. The amyloid aggregate of proteins is characterized by a common 
cross-β structure295,125–127,296,297. Many recent studies suggest that oligomers populated 
along the aggregation pathway rather than the final amyloid fibril are cytotoxic298–300. 
Motivated by advances in nanotechnology and nanomedicine, many studies focused on 
understanding impact of NPs with various physicochemical properties on protein 
aggregation in order to reduce protein aggregation upon NP exposure and also to find 
novel NPs that may inhibit aggregation. 
Given the diversity of NPs and proteins used in previous experimental studies, 
both aggregation inhibition and promotion effects have been reported. Amyloid 
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aggregation is a nucleation process, which is characterized by a lag time followed by 
sigmoid increase of amyloid fibrils301. Sara Linse et al. showed that copolymer particles, 
cerium oxide particles, quantum dots, and carbon nanotubes enhance fibril formation of 
b2-microglobulin130 with shortened aggregation lag time. Similar effect was seen when 
TiO2 nanoparticles were introduced to the Aβ solution132. It has been suggested that NPs 
locally increased protein concentration which enhanced the probability of the formation 
of critical aggregation nucleus301. On the other hand, Cabaleiro-Lago et al. found that Aβ 
and islet amyloid peptide (IAPP) fibrillation was inhibited by adding polymeric 
NPs130,133.  Guo et al. observed that singlewalled carbon nanotubes (SWCNT) prevent the 
formation of β-sheets of Aβ302. Similarly, Liao et al. showed that negatively charged gold 
nanoparticles inhibit Aβ fibrillization and relieved Aβ toxicity to neuroblastoma134. 
Interestingly, it was also noticed that a given NP might have a dual effect on protein 
aggregation depending on the relative concentration ratio between protein monomers and 
NPs (surface area). Since the protein to NP ratio determines the partition of proteins in 
solution and on NP surface, Cabaleiro-Lago et al. observed that amyloid aggregation of 
Aβ was promoted at a high protein to NP surface ratio and inhibited at the lower ratio 
(i.e., lower concentration of protein on NP surface)131. In order to fully harness the 
beneficial effects and reduce the adverse effects of NPs, it is necessary to uncover the 
driving forces that dictate the drastically different impacts of NPs on protein aggregation 
in addition to the kinetic effects. 
Depending on their core materials and surface coatings, various NPs have distinct 
physicochemical properties and thus different interactions with proteins. We hypothesize 
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that the complex aggregation behavior in the presence of NPs is also determined by the 
inter NP-protein interactions. Using coarse-grained modeling with discrete molecular 
dynamics (DMD) simulations, Auer et al. studied the dependence of protein aggregation 
on different protein-protein and protein-NP interactions. The NP was modeled as a single 
bead with attractive interaction to proteins. They observed that protein aggregation is 
enhanced by a stronger protein-NP interactions and NP surface served as fibrillization 
catalyst293. However, the experimentally observed inhibition of protein aggregation was 
not observed. We postulate that modeling NP as a single bead cannot capture some 
important aspect of surface diffusion, such as the surface roughness due to atomic 
surface. In this study, we explicitly modeled the surface atoms of a spherical NP (two 
atoms layers) and used Aβ as the model protein system, which is modeled by a simplified 
two-bead-per-residue model303. We probed the effect of varied interaction strength 
between NP and protein on Aβ aggregation. Using DMD simulations, we observed an 
optimal NP-protein interaction strength with which Aβ has the maximum aggregation on 
NP surface. With interactions weaker than the optimal value the increases of NP-protein 
interaction promotes aggregation. As the interaction strength is stronger than optimal 
value, Aβ aggregation was inhibited on NP surface. We also studied the concentration 
dependence of Aβ aggregation on NP surface. Our results shed light on the diverse effect 






2. Results and Discussion 
 In our two-bead-per-residue model188 for Aβ peptides, each amino acid is 
represented by the backbone Cα and sidechain Cβ beads model both intra- and inter-chain 
interaction, which has been extensively used by us and others to study protein 
aggregation in silico190 and the interaction potential is ε. We used the NMR structure of 
Aβ (PDB ID: 1BA4) βs the reference structure, where the protein is partially helical (Fig. 
6.1 A). In addition, we also included hydrogen bond interaction between backbone Cα 
beads (Methods). For the NP, we modeled the surface atoms as approximately closed-
packed on the 2D spherical surface with a diameter of 100 Å (Methods). We assigned 
non-specific attractive interactions between NP and protein atoms with the interaction 
potential of εNP. We kept NP atoms static and proteins free to move in DMD simulations. 
 Folding of Aβ monomer in solution. Before modeling Aβ aggregation under the 
influence of NP, we first characterized the folding dynamics of Aβ monomer in the 
absence of NP (or in solution) using replica exchange simulations304 (Methods). Eight 
replica were used with temperatures ranging from 0.45 to 0.80 ε/KB, and the incensement 
of 0.05 ε/KB, where ε is the interaction of Gō potential and KB is the Boltzmann constant. 
We used weighted histogram analysis method (WHAM)283 to calculate heat capacity (Cv) 
and radius of gyration (Rg) (Fig. 6.1). We observed two peaks in the Cv plot as the 
function of temperature (Fig. 6.1 B). Examination of Aβ structures at low temperatures (T 





Figure 6.1.  Protein stability curves. A) Amyloid β1-40 starting structure B) Heat capacity 
dependence on temperature of the protein in solution with depicted corresponding structure. C) 
Radius of gyration vs. temperature  
 The first peak at temperature T = 0.55 ε/KB corresponds to melting of the non-
native C-terminal helix. Due to the rigidity of a single helix, the unfolding of the non-
native C-terminal helix leads to the decreases of Rg (Fig. 6.1 C). As the temperature 
increases further, the native helix starts to unfold into random coil and the Rg of Aβ 
increases. Therefore, the second Cv peak at 0.65 ε/KB corresponds to the melting 
temperature, Tm. It is known that protein needs to be partially unfolded in order to form β-
sheet rich aggregates298. To facilitate the observation of protein aggregation in 
simulations, we performed our aggregation simulations at temperature T=0.655 ε/KB 
which is slightly above Tm. 
 Aggregation of Aβ petides on NP surface with different interaction strengths. 
Understanding how NP-protein interaction strength εNP influences the formation of 
amyloid aggregates is one of the key questions of this study. We varied the interaction 
strength εNP from 0.1ε to 0.7ε with the increment of 0.1ε. Ten Aβ monomers were 
 
A) B) C) 
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randomly positioned in the vicinity of the spherical NP. For each εNP, we performed 50 
independent DMD simulations with different initial positions and velocities. To quantify 
the aggregation process on the NP surface, we monitored the average number residues 
per chain that form inter-chain β-sheet like structures on NP surface, Nβ-Res (Methods). 
Here, we only included those Aβ peptides that were bound to the NP surface. By 
averaging over 50 DMD runs, we obtained the average Nβ-Res as the function of 
simulation time (Fig. 6.2 A). Usually, protein aggregation in solution is characterized by 
a lag time phase followed by a fast elongation phase305–307.  
In our simulations, we didn’t observe the lag time phase. We believe that due to a high 
local concentration of proteins on NP surface and the fact that we simulate at a 
denaturing temperature, the nucleation process is negligible. In our simulations, we 
observed that the aggregation reached plateau after a rapid elongation phase. For 
interactions εNP less than 0.3 ε, we found that the Nβ-Res has larger fluctuations compared 
to simulations with stronger NP-protein attractions. We found that large fluctuations 
resulted from a small number of proteins on NP surface due to weak NP-protein 





Figure 6.2. Aggregation on nanoparticle surface. A) Number of residues forming β-sheets per 
chain on NP surface B) Maximum number of residues in β-sheet structures per chain on NP 
surface 
To quantify the aggregation process, we used the sigmoidal function (Methods), 
routinely used to fit experimental protein aggregation data308, to fit computationally 
derived aggregation data (Fig. D1). From the fitting analysis, we obtained the maximal 
Nβ-Res as the function of NP-protein interaction strength εNP (Fig 2B). .We found that Nβ-
Res, which quantifies the average amount of β-sheet aggregation per chain on NP surface, 
has a maximal value near εNP = 0.3 ε. When εNP < 0.3 ε, increased NP-protein attraction 
leads to increased concentration of proteins bound to surface, which in turn enhance 
aggregation. As εNP is stronger than 0.3 ε, the increased interaction between NP surface 
atoms and proteins slowed down the diffusion of proteins on NP surface (Figure 6.4), 









Figure 6.3. Proteins on nanoparticle surface. A) Formed β-sheet aggregates on nanoparticle 
surface at interaction strength of 0.3 ε B) Denatured protein on nanoparticle surface at interaction 
strength of 0.7 ε 
 
The diffusion of proteins on the surface is governed by Arrhenius-type equation309: 
D=D0*exp(-Qa/kbT)  (6.1) 
Where Qa =n*E is the activation energy and n is the number of NP surface atoms in 
contact with the protein residue (bead). The linear fit (Fig. 6.4 inset) gave us value of 
Qa/kbT = 5.88 (Appendix D Table D1) from which we calculated the n to be 4, meaning 






 Visualized protein aggregation and structure configuration for interaction 
strengths of 0.3 ε and 0.7 ε are showed on Figure 6.3 A, B. Next, we examine the folding 
of NP monomer on NP surface with εNP = 0.3 ε 
Figure 6.4. Diffusion on nanoparticle surface. Mean square deviation (MSD) vs time of the 
protein on nanoparticle surface. Diffusion coefficient dependence on interaction strength (ln 
inline plot) fitted with ln(D)=ln(D0)-k*Interaction.  
 Aβ monomer is destabilized on NP surface. We placed an Aβ monomer on the 
NP surface with εNP = 0.3ε and performed replica exchange DMD simulations. Using 
WHAM, we estimated the specific heat at the function of temperature (Fig. 6.5). 
Compared to the Aβ in solution, we noticed a shift of Tm (the highest peak) to lower 
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temperature (Fig. 6.5). The destabilization of protein on the NP surface is possibly due to 
stabilization of the unfolded state, where the protein makes more contacts with the NP. 
Interestingly, there is a shoulder in the specific heat near temperature ~0.75 ε/KB. 
By calculating the probability of the protein in contact with NP, we found that this 
shoulder of Cv at high temperature corresponds to the dissociation of Aβ from the NP 
surface, Td. 
Figure 6.5. Stability of protein on nanoparticle surface. Heat capacity peaks moved towards 
lower temperatures (blue line) relative to heat capacity curve of the protein in solution (dashed 
line), indicating destabilization of protein structure due to nanoparticle surface binding. 
Emergence of the third peak at T=0.755 is reflection of the protein detaching from the 
nanoparticle surface (red line). 
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Therefore, at this intermediate NP-protein interaction strength εNP = 0.3ε, the protein was 
more destabilized on NP surface compared to in solution but still able to diffuse on 
surface, which in turn  promoted the formation of Aβ aggregates (e.g., the snapshot of Aβ  
aggregates as in Fig 6.3A). 
  
Figure 6.6. Protein aggregation dependence on concentration. A) Number of residues per 
chain in β sheet at interaction strength of 0.3 ε. B) Elongation rate dependence on number of 
monomers placed randomly onto nanoparticle surface. 
 The concentration-dependence of Aβ aggregation on NP surface. Our 
aggregation simulations suggested that with relatively weak NP-protein interaction the 
increased aggregation with increasing εNP is due to increased proteins on surface. Next, 
we performed DMD simulations to evaluate the concentration-dependence of Aβ 
aggregation on NP surface with the same interaction strength εNP = 0.3ε. We increased 
protein concentration from 2 to 10 monomers on NP surface. In each concentration, we 





function of time (Fig 6.6 A). Fitted with sigmoidal curves, we obtained the maximum 
amount of aggregates and the elongation rates, Ke of 7.92*10-4, 0.0135, 0.0629, 0.0673, 
0.0735 ns-1 in the case of 2, 4, 6, 8 and 10 monomeres, respectively (Fig 6.6 B).   
Figure 6.7.  Competition of protein aggregation on NP surface and in solution. Lag time 
histograms of amyloid beta aggregation in bulk with interaction switched off a) and at interaction 
strength of -0.225kcal/mol. Aggregation trajectories of amyloid beta in vicinity of nanoparticle 
surface with interaction switched off (black) and on (red) c). Average number of chains in 







Our results suggested that the elongation rate Ke increased with increased protein 
concentration. Interestingly, there is a transition of Ke between four and six monomers on 
NP surface, after which the increase in concentration didn’t have significant effect onto 
the elongation rate. We postulate that this transition between slow and fast elongation rate 
is possibly due to the protein cooperativity and reduced conformational entropy.  
 
 Competition of Aβ aggregation on NP surface and in solution. To further our 
understanding of protein aggregation in presence of nanoparticles, we conducted set of 
simulations with 6 Aβ monomers. Monomers were placed randomly away from 
nanoparticle surface. Firstly we simulated the system without assigned interactions, and 
then compared results when interaction strength was 0.225 kcal/mol. At this protein to 
nanoparticle ratio (6:1), we observed that protein aggregation lag time in solution away 
from nanoparticle surface was shorter (24 ns) compared to the one when weak interaction 
strength was assigned (26 ns) (Fig 6.7 A and 6.7 B). This is due to decreased local 
concentration in the bulk in presence of protein-nanoparticle interaction (Fig. 6.7 D). 
Also, after elongation phase proceeded at this concentration ratio, the influence of weak 
nanoparticle interaction onto protein aggregation dynamics in the bulk compared to the 
case when interaction was turned off was negligible (similar aggregation curve profile 
Fig. D3 A, B and distribution of average number of residues in beta sheets per chain Fig. 
D4 A, B). Contrary to the bulk, protein aggregation was observed in the vicinity of the 
nanoparticle when interaction was switched on, while lag time was diffusion limited (Fig. 
6.7 C). This result implies that at higher protein to nanoparticle concentration ratios, bulk 
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diffusion time to reach nanoparticle surface would be lowered and weak interactions 
could promote protein aggregation, creating locally crowded environment. In the case of 
lower protein to nanoparticle concentration ratios, attractive interaction of nanoparticle 
would keep proteins in its vicinity, but with lower local concentration, while depleting 
it’s concentration from the bulk. This would lead to two distinct aggregation processes: 
one that would take place on the surface of NP and the other in the bulk, with two distinct 
aggregation rates-one on the 2D nanoparticle surface kNP  and the other in solution ksol. 
 
Figure 6.8. Mechanism of NP influence on protein aggregation. A) Weak interaction with high 
protein to NP ratio at critical number of proteins in vicinity of NP surface n* such that kNP(n*)>ksol 
having promoting effect on protein aggregation  B) Weak interaction with low protein to NP ratio 
hinders aggregation due to reduction of protein from solution and small number of bound protein 
(n) to each NP having hindering effect on protein aggregation 
 These rate constants would depend on protein concentration (Fig. 6.6 B). 
Aggregation in the bulk would be hindered due to reduction of protein caused by 
nanoparticles attracting the protein near their surface, while the aggregation on the 




between proteins and individual nanoparticle (Fig. 6.6 A, B) . Thus, we conclude that the 
weak interaction between NP and protein can promote or hinder protein aggregation 
depending on relative concentration ratio between protein and nanoparticle (Fig. 6.8 A). 
On the contrary, in the case of the strong NP-protein interaction, the protein aggregation 
would be hindered independently of the relative concentration ratio (Fig. 6.8 B). 
 
3. Conclusion 
 In summary, our computational results showed that protein aggregation could be 
promoted or hindered in the presence of the nanomaterial depending on the interaction 
strength and relative concentration ratios between the protein and nanoparticle. In our 
DMD simulation study, we observed that as we increase interaction up to the turning 
point (Fig. 6.2 B), aggregation is promoted, after which it becomes hindered. Studies 
showed that graphene oxide sheets, carbon nanotubes and negatively charged gold 
nanoparticles that strongly interact with the Aβ hinder its aggregation134,294,310. Also, the 
study conducted by Cabaleiro-Lago et al. on Aβ aggregation in presence of polystyrene 
NPs, discovered dual effect of NPs on aggregation propensity related to relative 
concentration ratios between the protein and polystyrene nanoparticles131. Another study 
on scMN protein128, revealed that presence of copolymer nanoparticles accelerated 
aggregation of more thermally stable scMN mutants, while hindered aggregation of the 
less stable ones. Authors argued that less stable mutants when in contact with 
nanoparticle, are prone to unfold and establish more contacts with the nanoparticle’s 
surface, increasing the interaction strength and residence time compared to the more 
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stable mutants.  These studies are in agreement with our prediction that as interaction 
increases after the certain turning point (in our model 0.3 kcal/mol Fig. 6.2B, a 
nanoparticle has stronger effect in hindering fibrillation process. Also, we found that 
weak interactions locally increase protein concentration, and in that way locally promote 
aggregation. Because amyloid-beta has a strong potential to form nuclear seed308, effect 
of weakly binding nanoparticles like SiO2, ZrO2, CeO2, C60 and C70 doesn’t influence 
greatly lag time132 and aggregation process, which we observed in our computational 
studies (Fig. 6.7 A, B and Appendix D4). Study on IAPP aggregation in presence of 
copolymer particles133 revealed that residence time of the protein on surface of 85:15 and 
50:50 NiPAM:BAM was of the same order, 85:15 copolymer nanoparticles had 
significantly bigger effect in preventing IAPP aggregation than the 50:50 NiPAM:BAM. 
Because of the specific interaction nature between IAPP and NiPAM:BAM our model 
was unable to explain this behavior in terms of the interaction strength. Although, further 
studies are needed to address specificity of nanoparticle-protein interaction and its 
influence onto aggregation, our model can explain why some nanoparticles are better in 
promoting or hindering protein fibrilization process, depending on the strength of mutual 
interaction.    
 
4. Methods 
 Nanoparticle Model. Nanoparticle was modeled as two layers close packed all 
atom spherical nanoparticle of D=100 Å diameter. The VDW radius of atom was 
considered to be r=1.8 Å. Number of atoms calculated needed to form 2-layered closed 
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packing was N~5217. To determine this number we used formula N=(D2+(D-
2r√3/2)2)∙ρ2d/r2, where ρ2d=0.9069.  Atoms were uniformly distributed around the center 
in θ and φ coordinates, while in r direction distribution was Gaussian centered at 50 Å 
and with standard deviation of 7 Å. Then simulation was run at temperature of 0.6 
kcal/mol kb for 100 ns, then 0.7 kcal/mol kb for next 50 ns and at 0.85 kcal/mol kb for the 
last 50 ns, when atoms formed closely packed two layer nanoparticle (Appendix D5). To 
constraint sphere radius to 50 Å, we assigned infinite well bounded at 46.88 Å and 50 Å 
from the virtual atom at the center. 
Two-Bead Model of Protein. We modeled Ab protein (1BA4.pdb) using two-bead 
per residue model. Each amino acid is modeled using one bead for C-α (backbone 
carbon) and another one for C-β (side chain). Intra-molecular bonds along peptide are 
assigned to reflect protein geometry. Side chain-side chain interactions were modeled 
using structure-based potential, which favors observed native state interactions. The 
interaction strength between native contacts was set to ε=1 kcal/mol, while attractions 
between C-β atoms were assigned with hard-core distance of Dhc=3 Å and interaction 
range DIR=7.5 Å. Also, hydrogen bonds are included in this model between backbone 
atoms189. Each C-α can form maximum two hydrogen bonds with other C-α atom, and 
two bonds formed by one C-α are co-linear in order to model the angular dependence of 
hydrogen bonds. Other inter-atomic interactions are modeled by simple hard-core 
distance of 3 Å. 
Assigned Interactions Between Nanoparticle and Protein Residues. Attractive 
interactions between each nanoparticle atom and each residue atom were assigned with 
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distance range DIR=5.75 Å, and hard-core distance of Dhc=3.6 Å. Assigned interactions 
didn’t differentiate between different residues, i.e. they were non-specific (steps: 
Dhc=3.600000 3.800000 1.000000 4.300000 1.000000 4.550000 0.100000 5.250000 
0.020000 DIR=5.750000 εin). Attractive potentials used were εin = -0.1, -0.2, -0.3, -0.4, -
0.5, -0.6 and -0.7 kcal/mol.     
Simulation Set Up.: 
Amyloid-β Stability In Solution. Coarse-grained two-bead residue of protein was 
used. It was immersed in 200x200x200 Å3 simulation box with periodic boundary 
conditions. Firstly system was equilibrated at 0.45 kcal/mol kb for 5 ns and then eight 
replica exchange DMD simulations were run (0.45, 0.50, 0.55, 0.60, 0.65, 0.70, 0.75, 
0.80, and 0.85 kcal/mol kb)  for 3000000 time steps, which are approximately 150 ns. 
Using weighted histogram analysis method we calculated the heat capacity and radius of 
gyration.  
Amyloid-β Aggregation On Nanoparticle Surface At Different Non-Specific 
Interaction Strengths And Concentrations. Ten monomers were randomly placed in 
proximity of nanoparticle surface at temperature of 0.655 kcal/mol kb. Simulation box 
size was 205x205x205 Å3 with periodic boundary conditions. Prior to running 
simulations, we equilibrated system at above-mentioned temperature for 5 ns. For each of 
interaction strengths (-0.1, -0.2, -0.3, -0.4, -0.5, -0.6, -0.7 kcal/mol), we ran 50 
independent simulations with different initial conditions in duration of 50 ns.  For each 
simulation we analyzed number of residues in contact on nanoparticle surface and in 
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solution. Similarly, 50 independent simulations were performed with different 
concentrations (2, 4, 6, 8 and 10 monomers). 
Amyloid-β Stability On Nanoparticle Surface. Protein monomer was placed in 
simulation box of 205x205x205 Å3 size with periodic boundary conditions and 
equilibrated at temperature of 0.45 kcal/mol kb for 5 ns. After equilibration we ran eight 
replica exchange DMD simulations with temperatures ranging from 0.45-0.85 kcal/mol 
kb. Using weighted histogram analysis method we calculated the heat capacity.  
Simulations were run for 150 ns. 
Effect of Low Strength Nanoparticle-Protein Interaction On Protein Aggregation. 
To study how low interaction strength affects aggregation we placed six Aβ monomers 
randomly far away from nanoparticle. Size of simulation box in cases of switched on and 
switched off interaction was 205x205x205 Å3 and simulations were firstly equilibrated 
for 5 ns. After equilibration simulation was run for 50 ns at temperature of 0.655 
kcal/mol kb.  When interaction was switched off our εin=0 and when it was switched on 
εin=-0.225 kcal/mol. According to the distance of monomers from nanoparticle’s center, 
we separated proteins onto the ones at the vicinity of surface (< 62.00 Å from the center) 
and in the bulk (> 62.00Å from the center). Number of independent simulations ran was 
50, and for each simulation, the number of residues per chain in contact satisfying 
condition of β-sheet geometry was counted. Later this data was fitted with sigmoidal 
curves in order to get lag times for each simulation and then used to create lag time 
histograms in cases when attractive interaction was switched on and off. 
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Average Number of Residues in Contact. To quantify aggregation on nanoparticle 
surface we separated proteins that were on the surface from the protein in solution (bulk), 
by cut-off distance from the nanoparticle center Dcut-off=57.5 Å. Proteins with the distance 
less then Dcut-off were categorized as the ones on the surface. In order to measure extent of 
aggregation we counted number of residues that were aligned to satisfy b-sheet (parallel 
and anti-parallel) geometry. We considered two residues (i,j) in contact if their distance 
was less than 7.5 Å, and condition that they form sheet structure if additionally (i+1,j+1) 
and (i-1,j-1) are in contact for parallel, or (i+1,j-1) and (i-1,j+1) are in contact for anti-
parallel b-sheet. We ran 50 independent simulations with different initial conditions. For 
each simulation step it was calculated how many residues per chain are part of the sheet 
structure, and then it was averaged over 50 simulations at the same time step to get 
average number of residues in contact per chain at that instant.  
Aggregation Curve Fitting.  In order to get aggregation rate and aggregation 
maximum values we fitted aggregation curves in the case of protein placed at the 
nanoparticle surface with sigmoidal curves of the form: y=(A-B)/(1+exp(-kt))+B, using 
OriginLab 9.1 (Appendix D2). In case when protein were placed far away from the 
nanoparticle and let to diffuse to its surface the form of sigmoidal function we used was: 
y=(A-B)/(1+exp(k(t-t0)))+B, again using OriginLab 9.1. Lag time tlag was defined as 
tlag=t0-2/k, and calculated for each of 50 simulations, after which we created lag time 
histograms in OriginLab 9.1313 (Fig 6.7 A and  6.7 B). Simulation visualization (Fig. 6.3 






 This dissertation outlined my research on interaction between nanoparticles and 
biomolecules with the specific focus on its implications to protein structure, protein 
corona evolution and aggregation. It employed experimental and computational 
approaches to study molecular mechanisms responsible for corona formation and 
characteristics. Comprehension of the protein corona molecular level mechanisms would 
be essential for future nanomaterials application and production.  
 This work has addressed several topics, including Formation and Cell 
Translocation of Fibrinogen-Carbon Nanotube Protein Corona, followed by molecular 
dynamics effort to understand protein corona formation at molecular level in the 
following studies: Concept of Discrete Molecular Dynamic Simulations in Studying 
Protein Corona Formation, Effects of Nanoparticle Surface Chemistry on Nanoparticle 
Binding and Protein Structure, Differential Binding of Natural Amphiphiles to 
Nanosheets, Protein Aggregation Dependence on Nanoparticle-Protein Interaction and 
Relative Concentration. 
 
Formation and Cell Translocation of Fibrinogen-Carbon Nanotube Protein Corona 
 In this study, I examined the formation and stability of fibrinogen-carbon 
nanotubes protein corona in aqueous solution and in vivo. Characterization of protein 
corona was done through UV-Vis absorbance and fluorescence spectroscopy. From TEM 
images we concluded that protein corona on multiwalled carbon nanotubes was more of 
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complex morphology, while protein corona formed on singlewalled nanotubes was 
smoother. Through UV-Vis absorbance at 280 nm we followed the change in the 
absorbance peak of fibrinogen tryptophan residues over 10 h. Absorbance peak of 
fibrinogen-SWCNT protein corona dropped exponentially following diffusion-
sedimentation model, and eventually got stabilized after 400 min. On the contrary 
fibrinogen-MWCNT protein corona was stable in aqueous solution over all 10h. This 
suggests formation of “soft” corona in the case of SWCNT and “hard” corona in the case 
of MWCNT. Further fluorescence study backed this result. Quenching of Alexa Fluor 
546 labeled fibrinogen fluorescence intensity upon binding to carbon nanotubes was 
monitored over different nanotubes concentration. The data was fitted by Stern-Volmer 
equation and Stern-Volmer coefficients were extracted, suggesting higher quenching 
power of MWCNT over SWCNT, implying that MWCNT better favored the protein 
binding.  
  Then carbon nanotubes with already formed protein corona with dye labeled 
fibrinogen were introduced into HT-29 cell lines extracellular environment. The 
fluorescence of fibrinogen was recovered upon entering of SWCNT into the cell, while 
MWCNT were bound to the cell membrane without penetrating it, probably due to high 
energy cost for their endocytosis. The recovery of fluorescence meant that protein got 
detached from SWCNT upon entering the cell, suggesting differential interaction 
between SWCNT and fibrinogen with amphiphilic membrane. All this results imply that 
protein corona on SWCNT was of the “soft” character, owing to high curvature of 
SWCNT and its small radius which were less favorable for the alignment and adsorption 
119 
 
of the tubular fibrinogen molecules. To better understand molecular mechanism of 




Concept of Discrete Molecular Dynamic Simulations in Studying Protein Corona 
Formation 
 Here I examined formation of silver nanoparticle-ubiquitin corona. Ubiquitin is 
protein found in every eukaryotic cell. A silver nanoparticle was modeled to capture 
general properties of a metallic nanoparticle with predominantly hydrophobic atoms and 
small fraction of positively charged surface atoms. To mimic experimental conditions, 
negatively charged citrates were introduced onto nanoparticle surface through 
electrostatic interaction with positive surface atoms. Upon introduction of neutrally 
charged ubiquitins (pH 7.0), we observed displacement of citrate molecules from the 
nanoparticle surface and binding of ubiquitins. Although ubiquitin is negatively charged, 
it has 11 positively charged and 11 negatively charged residues. Near the protein helix 
surface there were identified residues with low negative potential that preferred binding 
to countercharges on NP surface. To evaluate if NP-ubiquitin interaction was 
electrostatically driven, we assigned higher electrostatic interaction between citrates and 
NP charged surface atoms. In this case citrate got more stabilized on the surface and 
resisted replacement by the protein molecules, leading to no ubiquitin bound to the 
surface. Consequently, we identified that electrostatic force was driving the formation of 
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the protein corona. After analysis of residue binding affinities, we found that residues 2 
and 18 have high binding propensity. In the NMR experimental study with gold 
nanoparticles and ubiquitin similar result was obtained and residues 2, 15 and 18 were 
found to bind the surface. The reason residue 15 didn’t have high number of contacts 
with the NP surface in our simulation was due it burial in the protein structure. This 
agreement between experimental result and the simulation highlighted the predictive 
power of our computational approach. 
 Further, protein corona kinetics was studied. Through the PMF construction based 
on center of the mass distances between nanoparticle and protein, and number of contacts 
between nanoparticle and identified residues that specifically bind to its surface, two 
peaks in PMF were identified. One corresponding to nonspecific binding and the other to 
specific binding.  The barrier dividing these two peak corresponds to reorientation of the 
protein, suggesting that protein reorientation was the rate limiting step towards specific 
binding. Further formation of corona through coarse grained protein model was examined 
with interaction based on atomistic DMD simulations. Competition between citrates and 
ubiquitins was observed, and formation of the first layer protein corona followed by the 
formation of the second layer. This was characterized by the number of unbound proteins 
over time, which was fitted to the stretched exponential function. The stretched 
exponential fit suggests heterogeneity in relaxation time which comes from replacement 
of citrates from the surface to form the first layer, and then slowing down of the binding 
rate when the formation of the second layer takes place. This implies the non-cooperative 
character of protein-protein interaction.    
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 Also both experimentally and computationally, destabilization of helical structure 
and increase in beta sheets was observed, further confirming the predictive power of our 
computational method in capturing protein corona effects. 
 
Effects of Nanoparticle Surface Chemistry on Nanoparticle Binding and Protein 
Structure 
 Surface functionalization of nanomaterials is commonly used method in order to 
broaden their biomedical application through enhanced solubility. In this study, I 
examined the effect of fullerene hydroxylation to ubiquitin structure. Different number of 
hydroxyl groups was randomly assigned to fullerene surface (0, 4, 8, 12, 16 and 20). 
According to binding preference these 6 different fullerene derivatives could be divided 
in two groups: hydrophobic corresponding to 0, 4 and 8 OH groups and hydrophilic with 
12, 16 and 20 OH groups. Fullerenols with 20 OH groups were observed to have two 
preferential binding site, with the one being near tyrosine, which was experimentally 
observed to have its fluorescence quenched with addition of fullerenols. This again 
affirms prediction of our computational method. Further, we observed that pristine 
fullerenes lead to protein denaturation once they got into hydrophobic core of the protein, 
while fullerenols (20 OH) stabilized protein structure.  
 As fullerenes are considered in potential use for drug delivery, it is important to 
investigate how its functionalization can adversely affect the biological system once they 
get introduced to it. This study suggest that hydrophobicity of the fullerenes may have 
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toxic effect once introduced to biological mille and that it is important factor to consider 
in order to use these nanomaterials in medicine.  
 
Differential Binding of Natural Amphiphiles to Nanosheets 
 Previous studies addressed genesis of the protein corona and its dynamics in the 
case of one biomolecule type involved. It is more realistic that once a nanoparticle gets 
into the biosystem it will interact with different types of molecules. Thus, I conducted 
study focused on binding affinities and protein corona evolution of natural amphiphiles 
likes sugars, small peptides and fatty acids to graphene and graphene oxide nanosheets. 
Here, we observed that graphene has higher affinity to bind these molecules owing to its 
more hydrophobic surface compared to more hydrophilic graphene oxide. On the other 
hand, fatty acids showed the highest affinity towards nanosheets due to their greater 
flexibility and carbon content compared to the sugar and the peptide. This differential 
binding affinity reflected on protein corona evolution. 
 In early times it was observed that the most abundant species-peptides and sugars 
were first to bind, but at longer times they got replaced by fatty acid that possessed 
highest affinity to bind the nanosheets. Consequently, we suggest that highly 
concentrated species with low surface affinity can initiate formation of the “soft” corona, 
but eventually high affinity specie will replace them and render “hard” corona on the 
nanoparticle surface. This study offers insights in the mechanistic understanding of the 




Protein Aggregation Dependence on Nanoparticle-Protein Interaction and Relative 
Concentration 
 It was found that nanoparticles can enhance of hinder the protein aggregation 
depending on the nanoparticle type and relative concentration ratios between NPs and 
amyloids. In order to identify undelaying parameters that control nanoparticle propensity 
towards protein aggregation, I performed DMD study on the coarse grained amyloid beta 
and metallic nanoparticle. This study, specifically addressed the aggregation dependence 
on the intensity of attractive interaction between NP and the protein and as well on their 
relative concentration.  
 The result suggest that in the case of weakly interacting NP-protein systems, 
propensity on the aggregation depends on the relative ratio between NP and protein. If 
protein:NP concentration ratio is high, weak interaction between NP and protein will 
effectively increase protein concentration around NP surface, promoting the protein 
aggregation. On the other hand, at low protein:NP concentration ratios, weak interacting 
NPs will drastically reduce the protein from the bulk, but due to high NP concentration, 
each NP will have as well low number of proteins around its surface, effectively 
hindering the aggregation. By increasing the interaction strength we saw increase in 
aggregation propensity on the nanoparticle surface up to the critical point after which 
interaction was too strong and consequently reduced diffusion rate. Reduced protein 
diffusion on the strongly interacting nanoparticle surface hindered protein aggregation 
independent of the relative concentration ratios between NP and the protein. In summary, 
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this study identified parameters that should be considered in order to predict aggregation 
effects of the specific nanoparticle onto amyloidogenic proteins. 
 
Future Directions 
 Future work related to this dissertation would concentrate on the study of protein 
crowding effect onto protein structure upon binding to the nanoparticle surface, as for 
example interior of the cell is highly crowded environment. Generally, it is adopted that 
crowding effect should have stabilizing effect onto protein due to reduced conformational 
entropy, but there are studies suggesting opposite. This is probably consequence of 
protein-protein interactions. It would be of great interest how crowding stabilizing effect 
competes with nanomaterials destabilizing effect onto the protein structure.  
 Also, when we studied protein aggregation in the presence of the nanoparticle we 
assigned non-specific interactions between nanoparticle surface and the protein. The next 
study should delineate how specific interaction influences protein aggregation, in the case 
when protein preferential orientation can induce differences in lag time and elongation 
rates. 
 Both these studies would give us better mechanical understanding of protein 
corona implications in biological environments and establishing pathway in responsible 



































Experimental characterisation of AgNP-ubiquitin corona. 
 Transmission electron microscopy imaging of AgNP-ubiquitin corona. Direct 
observation of formed AgNP-ubiquitin coronae was performed by transmission electron 
microscopy (Hitachi H7600). Specifically, AgNPs (10 nM) were incubated at room 
temperature in deionized water (18 MΩ-cm) at neutral pH with ubiquitin (5 µM) for 2 h, 
pipetted on a copper grid and negatively stained with phosphotungstic acid (optically less 
dense material) for 10 min prior to imaging. Similar procedures were performed for the 
protein-free control AgNPs (10 nM). 
 Hydrodynamic size and zeta potential measurements. Citrate-coated AgNPs 
(BioPure, nominal size: 10 nm) were purchased from NanoComposix and dispersed in 
Milli-Q water to form a stock suspension of 1 mg/mL (300 nM). Lyophilized ubiquitin 
(Boston Biochem, isolated from plant Arabidopsis thaliana) of 5 mg was dissolved in 
500 mL Milli-Q water to obtain a final concentration of 1 mM. The hydrodynamic sizes 
of AgNPs (34.9 nM), ubiquitin (10 mM), and AgNP-ubiquitin (molar ratio: 1:100; 
incubation: 2 h) were measured with three repeats each at room temperature using a 
Zetasizer (Nano-S90, Malvern) (Appendix A Fig. A1). In addition, the zeta potentials of 
AgNPs (4.97 nM), ubiquitin (5 mM), and AgNP-ubiquitin (molar ratio: 1:1000; 
incubation: 2h) were obtained at pH 6.5 using a Zetasizer (Nano, Malvern).  
 UV-vis absorbance measurement. To infer the binding of ubiquitins onto AgNPs 
we carried out an absorbance measurement using a UV-vis spectrophotometer (Cary 300 
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BIO, Varian). For this measurement the final AgNP concentration was 1.74 nM, while 
the final ubiquitin concentration was 50 mM. The mixture of AgNP-ubiquitin was 
incubated for 2 h prior to the measurement. An absorbance peak induced by the surface 
plasmon resonance of AgNPs upon excitation was observed at 393 nm, which was 
redshifted to 407 nm for the absorbance peak of the AgNP-ubiquitin mixture.   
 Circular dichroism spectroscopy. To determine changes in the secondary 
structures of ubiquitin upon nanoparticle-protein corona formation we performed a CD 
measurement using a JASCO J-810 spectropolarimeter. AgNPs and ubiquitins of a molar 
ratio of 1:1000 were incubated for 2 h and were diluted in quartz cuvettes to match the 
sensitivity of the instrument. CD spectra were acquired at room temperature over a 
wavelength range of 200-300 nm and averaged over five scans taken at a speed of 50 
nm/min. The backgrounds of the AgNP and ubiquitin controls were subtracted 
accordingly. The averages derived from the CONTINLL-4 and CONTINLL-7 methods 
were used to calculate percents of the secondary structures of the protein, based on the 
linear dependence between structural fractions and the spectra314. 
Computational modeling of AgNP-ubiquitin corona.  
 We combined both atomistic and coarse-grained molecular dynamics simulation 
to characterize the structure and dynamics of protein corona, where atomistic simulations 
were used to identify the binding modes between an individual ubiquitin and an AgNP, 
and coarse-grained simulations were used to characterise the corona formation between 
multiple ubiquitins and an AgNP. 
128 
 
 Discrete molecular dynamics simulation. Detailed descriptions for DMD 
algorithm can be found elsewhere264,311. Briefly, inter-atomic interactions in DMD were 
modeled by square-well potential functions. Neighboring interactions (such as bonds, 
bond angles, and dihedrals) were modeled by infinitely deep square-well potentials. 
During a simulation, an atom’s velocity remained constant until a potential step was 
encountered, upon which time it changed instantaneously according to the conservations 
of energy, momentum, and angular momentum. Simulations proceeded as a series of such 
collisions, with a rapid sorting algorithm used at each step to determine the subsequent 
collision. 
 The difference between DMD and traditional molecular dynamics is in the form 
of the interaction potential functions. Approximating continuous potentials with step 
functions, DMD simulations were reduced to event (collision)-driven molecular 
dynamics. The improved sampling efficiency of DMD over traditional molecular 
dynamics originates mainly from the rapid processing of collision events and localized 
updates of collisions (only collided atoms are required to update at each collision). At an 
adequately small step size, the discrete step function approaches the continuous potential 
function and DMD simulations become equivalent to traditional molecular dynamics. 
DMD simulations have been widely used to study biomolecules312, such as protein 
folding265, molecular recognitions315, and protein aggregation180. 
 Atomistic DMD model. We used the united-atom representation for proteins and 
citric acids (citrates), where all heavy atoms and polar hydrogens were explicitly 
modeled. The bonded interactions included covalent bonds, bond angles, and dihedrals. 
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We included van der Waals, solvation, environment-dependent hydrogen bonding 
interactions, and electrostatics in the non-bonded interactions. The solvation energy was 
modeled using the Lazaridis-Karplus implicit solvation model with the fully-solvated 
conformation as the reference stated183. The hydrogen bond interaction was modeled 
using a reaction-like algorithm316. In addition to the previous version of the atomistic 
DMD force field265, we also added electrostatic interactions between charges, including 
the basic and acidic residues in proteins180 and charged groups in small molecules. The 
interaction parameters for citric acids were adapted from the Medusa force field 
extension for small molecules281. We used the Debye-Hückel approximation to model the 
screened charge-charge interactions. The Debye length was set at approximately 10 Å by 
assuming water relative permittivity of 80, and a monovalent electrolyte concentration of 
0.1 mM. We used an interaction range of 30 Å for the electrostatic interactions, where the 
screened potential approached zero.  
 AgNP model. Because our knowledge of the interactions between nanoparticles 
and proteins is still lacking, there are no well-accepted force fields that can readily 
capture the binding between AgNP and proteins. In order to model the formation of 
AgNP-ubiquitin corona, we developed a simple model for simulating AgNP. Since the 
interactions between AgNP and proteins take place primarily on the surface of AgNP, we 
only explicitly modeled the surface atoms. The VDW radius of a silver atom is r=1.72 Å. 
Assuming close packing of silver atoms on the surface, we can calculate that the number 
of surface atoms for an AgNP with the diameter D=100 Å is N=πD2ρ2d/πr2, where ρ2d is 
the close packing density of ~0.84. Therefore, the total number of silver atoms is ~2,830 
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in one AgNP. We grouped every three atoms into one coarse-grained silver atom with a 
VDW radius of ~2.98 Å, and the number of surface atoms was reduced to 943. We 
introduced one atom in the center of the AgNP, and imposed distance constraints between 
the center and surface atoms at [49.5 Å, 50.5 Å]. As a result, all surface atoms effectively 
remained on the AgNP surface during simulations. 
 The same coarse-grained AgNP model was used in both all-atom and coarse-
grained DMD simulations. In the all-atom simulations, the non-bonded interactions for 
AgNP surface atoms included van der Waals, solvation, and electrostatics. The VDW 
interaction between two atoms (i and j) in Medusa is proportional to (εiεj)0.5, where εi0.5 is 
the dipole polarisability of atom i. We assigned ε=0.4 for the coarse-grained surface 
atoms (comparing to ε=0.12 for carbonyl carbon in CHARMM 19317). For the Lazaridis-
Karplus solvation interaction183, we assumed a coarse-grained surface atom is 
hydrophobic and the free energy ΔG for excluding it from water is -2 kcal/mol.  
 AgNP is usually synthesized by chemical reduction of Ag+ salt and capped by the 
negatively charged citric acid, or citrate318. Due to incomplete reduction, it is likely that 
there are residual silver ions on the AgNP surface that bind to citrates. The citrate-capped 
AgNP alone had the zeta-potential of -45.0 mV, suggesting excessive citrate molecules. 
We randomly selected a subset of the surface atoms and assigned positive charges. We 
initially assigned +e to the charged surface atoms and performed equilibration 
simulations with excessive citrates. We found that citrate molecules with -3e had the 
tendency to attract multiple charged surface atoms (~3) to its vicinity, forming charged 
clusters (Appendix A Fig. A4). Since the charge-charge interactions are long-ranged and 
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their calculations in DMD are proportional to the square of total number of charged 
atoms, we decided to assign a positive charge of +3e to the charged surface atoms in 
order to increase DMD sampling efficiency by reducing excessive calculations. 
 In the all-atom DMD simulations, the units of mass, length, and energy are Dalton 
(1.66x10-24 gram), angstrom (10-10 meter), and kcal/mol (6.9x10-22 joule), respectively. 
Given the units of mass [M], length [L], and energy [E], the time unit (t.u.) can be 
determined as approximately 50 femtoseconds. 
 Calculation of contacts between AgNP and ubiquitin. We defined a contact 
occurred between an ubiquitin residue and the AgNP when the distance between the 
AgNP center and the corresponding Cβ atom of the residue was less than 57.5 Å. The 
protein was assumed to be AgNP-bound if at least one residue was in contact with the 
AgNP, and the contact frequency between each residue and the AgNP was averaged over 
the total time that the protein remained bound to the AgNP. 
 Calculation of 2D-PMF. We first computed the 2D-histogram with respect to the 
center-of-mass distance between AgNP and ubiquitin, dcm, and the number of contacts 
between AgNP and the subset of residues identified to bind specifically to AgNP, Nc. The 
inter-molecule distance dcm was sampled from 60 Å to 120 Å with the bin size of 2.5 Å, 
while the sampling of Nc was from 0 to 13 with the bin size of 1. The 2D-PMF was 
simply computed proportional to the logarithm of population, -KbTln(P). Here, Kb is the 
Boltzmann constant and P is the population. 
 Coarse-grained molecular system. We used a two-bead-per-residue protein model 
for the study of corona formation between multiple ubiquitins and an AgNP188,189. In the 
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two-bead model, each amino acid was represented by only the α-carbon (backbone) and 
β-carbon (sidechain). The bonded interactions between neighboring atoms along the 
peptide chain were assigned to mimic peptide geometry188. We used a structure-based 
potential to model the sidechain-sidechain packing interactions, where native interactions 
observed in the native state were favored. Two interacting residues can form either intra- 
or inter-monomer contacts, in order to promote protein-protein association189,190. The 
attractions between the residue β-carbons were assigned with a hard-core distance of 
Dhc=3 Å and an interaction range of DIR=7.5 Å. The interaction strength of the native 
contact was ε, which was set as 1 kcal/mol. We also modeled the backbone-backbone 
hydrogen bond interaction as in Ref.189 where each Cα can maximally form two hydrogen 
bonds with other Cα atoms, and two hydrogen bonds formed by one Cα atom are aligned 
co-linear189 in order to model the angular dependence of hydrogen bonds. Other inter-
atomic interaction for proteins was simply hard sphere collisions with the hardcore 
distant of Dhc=3 Å. 
 We determined the folding thermodynamics of an isolated coarse-grained 
ubiquitin by replica exchange DMD simulations180. Using weighted histogram analysis 
method268,283, we calculated the specific heat and RMSD of ubiquitin as the function of 
simulation temperature (Appendix A Fig. A2). The specific heat featured a single peak at 
Tf = 340K, which corresponded to the melting temperature of the protein. Below Tf the 
protein remained folded with low RMSD, which was comparable to all-atom simulations 
(Fig. 3b). Above Tf, the protein became unfolded with large RMSD. 
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 Each citric acid was represented by one coarse-grained atom. We used the same 
AgNP model as described above and assigned a strong attraction between citrates and the 
charged AgNP surface atoms. The citrates showed a weak repulsion to ubiquitin to mimic 
the mutually exclusive binding to AgNP as observed in atomistic simulations. We 
assigned a more favorable attraction between the charged AgNP atoms and the AgNP-
binding residues (residues 18, 19, 20, 21, 22, 24, 25, 28, 52, 54, 55, 57, and 58), 
compared to the rest of the protein. The interaction parameters are summarized in the 
Appendix A Table A1.  
 Simulation setups and conditions. i) Atomistic simulations. The molecular system 
was composed of one AgNP, one ubiquitin, and 50 citrates. The molecules were placed in 
a 150 x 150 x 150 Å3 cubic box with periodic boundary conditions. We set a subset of 40 
surface atoms of AgNP (randomly distributed) as positively charged (3e), and kept the 
center atom fixed during the simulations. The simulation temperature was maintained at 
300 K using an Andersen thermostat319. The molecular system of the AgNP and citrates 
was equilibrated at first in order to let citrates bind to the surface charges (Appendix A 
Fig. A5). In the control simulations of artificially enhanced electrostatic interactions 
between citrates and the AgNP, we added an additional charge (-e) to the C6 atom of the 
citrate molecule (Appendix A Fig. A6) 
 ii) Coarse-grained simulations.  There were one AgNP, 25 (or 50) ubiquitins, and 
80 citrates in a 300 x 300 x 300 Å3 cubic box with periodic boundary conditions. A 
subset of 60 AgNP surface atoms was positively charged, and the AgNP center was also 
kept static. We performed the simulations at a constant temperature of 325 K, which was 
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set to enhance the kinetics while still below the melting point (Appendix A Fig. A2). 
 Fitting analysis of the AgNP-ubiquitin binding kinetics. We used the least square 
(χ2) approach to fit the ubiquitin-AgNP binding data derived from coarse-grained DMD 
simulations. Since the data was approximately linear in the log-log plot (Fig. 1.4 & 
Appendix A Fig. A7), we fitted the data with three different models, including a power-
law, ~tα, a stretched exponential, ~1-exp(-ctα), and a cumulative lognormal, 
~1+erf(cln(t/τ)). Here, erf is the error function. Among three fitting models, the power-
law gave the largest χ2-value, 962.4. The fitting for both the stretched exponential and 
cumulative lognormal functions were similar, with χ2-values equal to 469.1 and 486.8, 
respectively. A lognormal distribution is usually used to describe the data where the value 
is the multiplicative product of many independent random variables. The relaxation time 
cannot be modeled as the product of a large number of independent random variables. On 
the other hand, a stretched exponential function is often used to describe the relaxation 
kinetics with high heterogeneity in relaxation time, where the kinetics can be described as 
linear superposition of exponential decays with continuous distribution of relaxation 
time. A similar stretched exponential binding kinetics has been observed in a 
fluorescence study of protein binding to colloidal nanoparticles191. Therefore, the 

































Figure A2. The folding thermodynamics of the coarse-grained ubiquitin. The specific heat 
(A) and RMSD (B) were computed as the function of the simulation temperature using replica 
exchange simulations and weighted histogram analysis. The error bars were computed as the 




Figure A3. The kinetics of ubiquitin-AgNP binding. (a) The number of ubiquitin molecules 
bound to AgNP, Nbound, as the function of time (in DMD time unit, t.u., see Supporting 
Information) from a typical DMD simulation. The backbone trace of ubiquitin (rainbow color) is 
shown. The citrates correspond to the red spheres. The large gray sphere denotes the AgNP, and 
the blue spheres on the surface of the AgNP are the positively charged atoms. The insert 
illustrates the association and dissociation of a ubiquitin (in red). (b) The snapshots along the 
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DMD simulation trajectory demonstrate the non-specific binding between incoming ubiquitin and 






Figure A4. The equilibration of citrates and AgNP. The coarse-grained surface atoms are 
shown as spheres, where the charged atoms are colored blue and uncharged atoms are gray. The 
citrate is shown in stick representation. (A) Initially, the charges (+e) were randomly distributed 
on the surface and citrates were not bound. (B) During the equilibration simulations, the citrates 






Figure A5. The equilibrated state of citrate-capped AgNP. The charged surface atoms (+3e) 
are shown as blue spheres, and the rest surface AgNP atoms are represented as gray spheres. The 
negatively-charged citrates (-3e) bind to the charged AgNP surface atoms, while there are 
excessive citrates in the solution. 
 
Figure A6. The molecular structure of citrate. The citrate molecule is in stick representation 




Figure A7. The ubiquitin-AgNP binding kinetics. The average number of ubiquitins bound to 
AgNP, <Nbound>, was computed as the function of simulation time in a log-log plot (black line). 
Using the least square method, the data was fitted with a power-law (red line), a stretched 
exponential (blue), and a cumulative lognormal (brown). 
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Table A1. Interaction parameters between coarse-grained atoms. Most of the interactions 
were modeled by a single-well DMD potential, where Dhc denoted the hard-core distance, DIR 
indicated the interaction range beyond which two atoms did not interact, and Erep and Eattr 
corresponded to the repulsive (>0) and attractive (<0) energy steps, correspondingly. The energy 
unit, ε, was set as 1 kcal/mol. A hard sphere collision potential between atoms was defined by the 
hard-core distance, Dhc. The charged AgNP surface atoms interacted with each other via the 
screened electrostatic repulsion as described in the all-atom simulations (Methods). The AgNP-
binding involved residues 18, 19, 20, 21, 22, 24, 25, 28, 52, 54, 55, 57, and 58, which featured  
high contact frequencies as revealed by the all-atom simulations. The interactions between inter-  
and intra-protein atom pairs were modeled by the structure-based potentials189,190.  
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Figure B1. The binding sites of C60(OH)20 fullerenol on ubiquitin as predicted by docking 
simulations. The residues that make direct contact with ubiquitin include Phe45, Asn60, 
Gln 62 and Ser65 at site 1 (A), and Leu71, Leu73, Gly75 and Gly76 at site 2 (B), which 
are highlighted by depicting in stick representation. The C60 fullerene bind predominantly 













Figure B2. Stern-Volmer plot of fluorescence quenching of ubiquitin in the presence of 





















Figure B4. Representative RMSD plots of ubiquitin without any nanoparticles from 












Figure B5. Protein heavy atom RMSD fluctuations in MD simulations in the cases of 




























Figure C1. The high-energy normal mode of the graphene oxide nanosheet. The simulations 
were done with the nanosheet alone. (a) At T~0.67 kcal/mol·kB, the fluctuation of the potential 
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energy indicated excitation of a higher-energy normal mode. (b) The snapshots of the nanosheet 






Figure C2. Raman spectra of graphene oxide before and after incubation with algal 
exudates. The absence of any shift in the 2D-band (~2730 cm-1) suggests that the interaction 





Figure C3. Palmitic acids (purple) were observed to bind to each other before their 
adsorption onto the nanosheet in one of the simulations.  
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 Figure D3. Non-averaged aggregation trajectories. A) Number of residues in β-sheets per 







Figure D4. Influence of weak interaction on protein aggregation in solution. A) Average Nβ-
res over first 25 ns distribution in presence of NP  B) Average Nβ-res over first 25 ns distribution in 




Figure D5. Nanoparticle model with two layers of atoms and radius of 5 nm. 
 
Equation D=A*exp(-B*x) 
Weight Not weighted 
Res. Sum. of Sq. 0.02137   
Pearson’s r -0.99692   
Adj-R Sq. 0.99181   
  value STD 
 
D 
intercept -3.33765 0.13869 
slope -5.87947 0.26691 
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